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The endoplasmic reticulum (ER) is a complex, multifunctional organelle 
comprised of a continuous membrane and lumen that is organized into several functional 
regions. It plays various roles including protein translocation, folding, quality control, 
secretion, calcium signaling, and lipid biogenesis. Cellular protein homeostasis is 
maintained by a complicated chaperone network, and the largest functional family within 
this network consists of proteins containing tetratricopeptide repeats (TPRs). TPRs are 
well-studied structural motifs that mediate intermolecular protein-protein interactions, 
supporting interactions with a wide range of ligands or substrates. Nine TPR-containing 
proteins have been shown to localize to the ER and control protein organization and 
homeostasis within this multifunctional organelle. Here, we discuss the roles of SEL1L, 
ERdj6, FICD, TMTC1-4, TTC13 and TTC17 and how they contribute to controlling ER 
processes and organization. The crucial roles that TPR-containing proteins play in the ER 
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(Sections from this chapter are adapted from (Graham et al., 2019)) 
1.1 A historical perspective of endoplasmic reticulum morphology, organization and 
function. 
In eukaryotic cells, cellular processes are frequently organized into specific 
subcompartments or organelles. The endoplasmic reticulum (ER) is comprised of a single 
lumen and contiguous membrane that spreads throughout the cell, commonly making it 
the largest organelle within a cell. The ER was first observed in 1902 by Emilio Veratti 
when he used Camillo Golgi’s staining method and found a cellular structure distinct 
from the Golgi apparatus. It was not until 1953 that the ER was named and acknowledged 
to be an organelle. With the development of electron microscopy, Keith Porter and 
George Palade validated the presence of a net-like (reticulum) structure within (endo) the 
cytoplasm (plasmic) via high-resolution electron microscopy (EM) imaging (Palade and 
Porter, 1954; Veratti, 1961). Palade also developed a method to isolate ER-derived 
“microsomes” and in combination with microscopy-based analyses, extensive 
biochemical assays were performed leading to the discovery that the ER participates in a 
number of essential processes including protein folding, quality control, trafficking, 
secretion and homeostasis, calcium signaling, and lipid biogenesis and regulation (Caro, 
1964; Lamriben et al., 2016; Mazzarello et al., 2003; Palade and Siekevitz, 1956; Stein 




subdomains characterized by the enrichment of specific factors exist within this singular 
luminal space of the ER, creating functional sub-regions (Lynes and Simmen, 2011). 
Early microscopic and biochemical observations showed two distinct domains of 
the ER: the rough ER, characterized by the presence of ribosomes, and the smooth ER 
that is devoid of ribosomes. Extensive studies on the rough ER have provided numerous 
breakthroughs in understanding its function but progress on the smooth ER has been 
slower.   
The rough ER membrane is easily distinguishable in EM images as it is studded 
with ribosomes that provides the rough appearance. Using combined EM and 
autoradiography, the flow of proteins from the cytoplasm, through the ER, and onwards 
to the Golgi was observed and provided primary evidence that the ER is the site of entry 
into the secretory pathway (Caro, 1964). Ribosomes are nestled onto translocons (Sec61) 
embedded in the ER membrane that provide the conduit for translocation into the ER 
lumen (Park and Rapoport, 2012). Proteins resident to the rough ER include translocon-
associated factors such as proteins involved in signal sequence processing or 
glycosylation, as well as molecular chaperones (i.e. BiP, calnexin and calreticulin) and 
oxidoreductases (i.e. PDI and Erp57) that assist the folding and maturation of the newly 
synthesized polypeptides (Alder et al., 2005; Harada et al., 2009; Johnson and van Waes, 
1999; Shibatani et al., 2005). The signal sequence peptidase and glycosyltransferase 
complexes, as well as chaperones and oxidoreductases, are known to participate in co-
translational events in the rough ER but they may also be observed in other regions of the 





Over the last two decades, work pertaining to the smooth ER has identified and 
characterized several subdomains including ER exit sites (ERES) and the ER quality 
control compartment (ERQC-C) (Benyair et al., 2015a; Budnik and Stephens, 2009). 
ERES mediate the export of secretory cargo from the ER and generate the ER-Golgi 
intermediate (ERGIC) compartment (Jensen and Schekman, 2011). This portion of the 
ER is part of the transitional or intermediary ER, characterized by its overlap with the 
rough ER and its transition into the Golgi vesicular network. An emerging subdomain of 
the ER is the ERQC-C. In order to ensure proper protein processing, nascent proteins of 
different folding states must be segregated by distinguishing properly folded proteins at 
ERES for export to the Golgi from those that are terminally misfolded for targeting for 
ER-associated degradation (ERAD) in the ERQC-C (Benyair et al., 2015a). It has been 
suggested that a number of the ER quality control factors, as well as accumulated 
misfolded secretory cargo, are also collected into peri-centrosomal vesicles, or quality 
control vesicles (QVCs) (Benyair et al., 2015b). However, these membrane enclosed 
QVCs and the localization of ERAD and ERQC factors are not well defined.  
To maintain cellular homeostasis, organelles are connected by vesicle-mediated 
trafficking and membrane contact sites where two heterologous membranes are closely 
apposed (~within 30 nm) but do not fuse. The ER forms membrane contact sites with 
multiple membrane systems including the plasma membrane, mitochondria, Golgi, 
endosomes, and lipid droplets (Zhang and Hu, 2016). Association of the ER with other 
organelles generally involves portions of the smooth ER and protein-protein interactions 
and/or protein-phospholipid interactions between the ER and the apposed organelle. The 




demands of the contact, which include lipid and calcium exchange, fission and organelle 
movement. 
The first role shown to be associated with the ER was calcium storage as Ca2+ 
was observed to be sequestered in the sarcoplasmic reticulum (the term for the ER in 
muscle cells) (Mazzarello et al., 2003). The mechanisms by which the ER sequesters and 
releases Ca2+ gave essential insight into the studies of muscle contraction, signaling, 
fertilization and neurotransmission (Hales et al., 1974; McGraw et al., 1980). Whereas 
some calcium binding proteins, like calreticulin, or re-uptake pumps, like SERCA, appear 
to be widely distributed throughout the ER, IP3 receptors and ryanodine receptor calcium 
channels are often found clustered within the smooth ER (Satoh et al., 1990; Takei et al., 
1992). 
The use of microscopic radioautography demonstrated the intracellular movement 
of labelled lipids, showing lipids were observed in the rough and smooth elements of the 
ER then in mitochondria and Golgi shortly thereafter. It was concluded that these lipid 
particles represented lipoproteins that formed in the ER, were processed in the Golgi and 
then transported into vacuoles to be dispersed into circulation (Stein and Stein, 1967). 
Lipid and calcium exchange and regulation between the ER and rest of the cell was later 
determined to be attributed mainly to the ER forming physical membrane contacts with 
the plasma membrane and mitochondria (Giorgi et al., 2009; Hayashi et al., 2009; Pichler 
et al., 2001). 
The domain of the smooth ER found in close contact with the plasma membrane 
is termed the plasma-associated membrane (PAM) (Pichler et al., 2001). A significant 




lipid transfer. The mitochondria-associated membranes (MAMs) are important for energy 
metabolism and regulated cell-death, therefore they are pivotal for cellular function and 
survival. MAMs also enable highly efficient transmission of calcium from the ER to 
mitochondria to stimulate oxidative metabolism (Boehning et al., 2003; Rizzuto et al., 
1998; Simmen et al., 2010). Additionally, the smooth ER is now known to provide the 
point of origin for entire organelles such as the peroxisome, Russell bodies, and lipid 
droplets (Kalantari et al., 2010; Kopito and Sitia, 2000; Mast et al., 2010).  
A multitude of cellular functions rely on adaptor proteins and multi-protein 
complexes to mediate compartmentalization and organellar contact sites. A number of ER 
resident factors utilize protein-protein interaction motifs to nucleate multi-protein 
complexes directing, at least in part, the formation of ER subdomains (Zhang and Hu, 
2016). A better understanding of the employment of adaptor proteins and protein-protein 
interaction motifs could lead to a more complete understanding of ER functional 
organization. This thesis aims to describe how proteins containing TPR motifs contribute 
to the roles and functional organization of the ER. 
1.2 Structure and function of TPR domains 
Adapter or scaffold proteins commonly utilize repeat motifs to nucleate protein 
complexes since repeats allow a variety of binding surfaces with minimal sequence 
variation. They are comprised of tandem repetitions of a short structural motif and have 
been used as molecular recognition tools in a wide variety of applications (Sawyer et al., 
2013). Examples of repeat proteins are Leucine Rich Repeats (LRR), ankyrin repeats 
(Ank), the WD40 repeat, the armadillo repeat (ARM), and the TPR. Each of these motifs 




(Good et al., 2011; Sawyer et al., 2013). The TPR is of particular interest because they 
are found in numerous proteins, serving as interaction modules and multi-protein 
complex mediators, and recently TPR-containing proteins were found to comprise 
approximately one third of the mammalian protein chaperone network in the cell 
(Brehme et al., 2014; Zeytuni and Zarivach, 2012). 
Since their identification, TPR-containing proteins have been found in all 
kingdoms of life and to regulate a number of diverse biological processes including 
protein folding and import, organelle targeting and vesicle fusion. A single TPR motif 
consists of 34 amino acids in a degenerate consensus sequence defined by a jig saw 
pattern of small and large hydrophobic amino acids. Though this general consensus 
sequence or pattern describes TPR motifs, no residue is invariant; however, residue type 
is highly conserved at three positions (8, 20 and 27) relative to the motif’s N-terminal 
residue (D’Andrea and Regan, 2003; Magliery and Regan, 2005). 
The canonical unit of the TPR adopts a basic helix turn helix fold, and adjacent 
TPR units form a series of repeating antiparallel α-helices (Figure 1.1A). This yields an 
overall super-helical structure affected by the residue found between adjacent motifs and 
the number of repeats next to one another. A positive correlation was determined between 
protein thermostability and the number of TPR motifs using a non-natural recombinant 
TPR-containing protein with 20 sequential TPRs (Kajander et al., 2007). Additionally, 
increasing numbers of TPR motifs confer kinetic folding cooperativity and were shown to 
involve the thermodynamic interplay between the stability of individual repeats as well as 




TPR-containing proteins use different binding pockets to bind diverse ligands that 
usually do not share secondary structure or sequence similarities. Although a defined rule 
set is lacking, binding is usually highly specific. The crystal structures of many TPR-
domain containing proteins show two anti-parallel -helices packed in tandem arrays to 
form a structure with an amphipathic groove which can bind a target peptide (Grove et 
al., 2008; Zeytuni and Zarivach, 2012). This is not, however, the only mode of target 
recognition by TPR domains, with short amino acid insertions and alternative TPR motif 
conformations also shown to contribute to protein interactions, highlighting diversity in 
TPR domains and the versatility of this structure in mediating biological events (Allan 
and Ratajczak, 2011). In nature, TPR motifs can be found in tandem arrays of 2-16 
sequential motifs (D’Andrea and Regan, 2003; Jiménez et al., 2012). Clusters of three 
TPR tandem motifs are the most common, and they form a distinct curve, binding the 
ligand on the concave side (Figure 1.1B) (Scheufler et al., 2000).  The binding of ligands 
for clusters of three TPRs seems to be more specific, whereas when higher numbers of 
repeats are found adjacent to one another, the binding is more promiscuous (D’Andrea 
and Regan, 2003; Jínek et al., 2004). 
To obtain such diverse binding, the TPRs utilize their distinct fold to serve as an 
interaction platform. This platform can exhibit different surface residues in each binding 
surface, yielding specificity by a combination of factors (Zeytuni and Zarivach, 2012). 
Residue type affects the electrostatic nature of the binding surface by contributing 
positive and negative charges. Additionally, residues with different hydrophobicity and 
size can support hydrophobic interactions between TPR domains and ligands. The 




conformation, or a combination of the two. Elongated conformation maximizes the ligand 
surface presented to the TPR domain, as well as optimizes H-bond formation and thereby 
facilitates the specific recognition of the short amino acid stretches. Given the 
complicated organization of the ER, which in part is directed by the formation of multi-
protein complexes, and TPR-containing proteins possessing intracellular signaling 
scaffold, spatial organization, and assembly-line properties, TPRs may contribute to the 
ER’s various functions. Nine proteins containing TPRs have thus far been shown to 
localize to the ER and contribute to its diverse cellular functions (Figure 1.2) (Kaneko 
and Nomura, 2003; Li et al., 2018; Preissler et al., 2015; Racapé et al., 2011; Sunryd et 
al., 2014; Yan et al., 2002). The roles and functions of these nine proteins will be 
discussed below. 
1.3 Functional roles for ER TPR-containing proteins 
1.3.1 Protein translocation across the intracellular membranes 
Protein translocation is a process by which a polypeptide chain moves across a 
membrane (Blobel, 1980; Schnell and Hebert, 2003). The protein is frequently directed to 
its target membrane by an N-terminal signal sequence and protein translocation can occur 
co-translationally or post-translationally. TPR-containing proteins have been shown to be 
essential for a number of cellular translocation processes as cells or organisms lacking 
these proteins exhibit growth and survival defects (Harkness et al., Nieuwkoop et al., 
1994; Sun et al., 2014). In order to better understand the function of TPR-containing 
proteins involved in translocation across the ER membrane, we first describe one of the 




proteins across the outer mitochondrial membrane to provide framework for 
translocational roles. 
The majority of mitochondrial proteins are synthesized by cytosolic ribosomes 
and then imported into the organelle post-translationally. TOM (the translocase of the 
outer mitochondrial membrane) is a multi-protein complex that contains surface receptors 
for pre-protein recognition and a translocon that serves as the membrane conduit to cross 
the outer mitochondrial membrane. The translocase complex is comprised of at least 
seven proteins, including TOM70 and TOM20, both of which contain TPR motifs. 
Mitochondrial targeting requires the cytosolic molecular chaperones Hsp70 and Hsp90, 
and their chaperone activity and substrate binding is regulated by a number of co-
chaperones, of which some contain TPR motifs (discussed below in the chaperone 
networks section). TOM70, the mitochondrial import receptor, is also a member of the 
TPR co-chaperone family as it contains a conserved TPR-clamp domain comprised of 
three TPR motifs for interaction with Hsp70 and Hsp90 (Young et al., 2003). Cellular 
studies on this interaction between human TOM70 and chaperones has shown it to be 
important for preprotein import preparation and the initiation of the import process (Fan 
et al., 2006). TOM70 also contains an additional two clusters of TPRs (each containing 
three TPR motifs), which may be involved in preprotein recognition and translocation 
(Wu and Sha, 2006). TOM20 contains a single TPR motif, which is unique in TPR 
functional analysis. The structures of both rat and yeast TOM20 reveal that the single 
TPR motif along with a third helix form a hydrophobic groove, which is the binding site 
for N-terminal presequence peptides aiding in transport cargo recognition (Muto et al., 




protein import and how the different TPR functional domains exhibit various binding 
specificities. 
In the secretory pathway, TPR-containing proteins have been shown to be crucial 
for protein translocation both into and out of the ER (Figure 1.3). ER post-translational 
translocation in yeast requires the Sec61 translocon channel and a complex of 4 
additional proteins: Sec63, Sec62, Sec71 and Sec72 (Itskanov and Park, 2019; Wu et al., 
2018). Using a combined structural and biochemical approach, the role of the C. 
thermophilum Sec71/72 subcomplex was determined (Tripathi et al., 2017). The crystal 
structure reveals that Sec72 contains a TPR domain that has multiple chaperone 
interaction sites and is anchored to the ER membrane by Sec71 and Sec63. This TPR 
domain interacts with the C-terminus of Ssa1, cytosolic Hsp70, which binds to the 
concave inner surface of the TPR domain. Surprisingly it also interacts with Ssb1, a 
cytoplasmic Hsp70 that binds ribosome associated nascent polypeptide chains even 
though it lacks the C-terminal TPR-binding residues of Ssa1. Ssb1 instead interacts with 
the TPR domain through its ATPase domain along the backside (convex) of the TPRs 
allowing for translocation substrates to be recruited to the Sec71/72 complex both co- and 
post-translationally (Tripathi et al., 2017). Recent cryo-EM data reveals that Sec63 
positions Sec71/72 for the capture of polypeptides associated with cytosolic Hsp70, an 
interaction mediated by the TPR domain of Sec72 (Figure 1.3A) (Itskanov and Park, 
2019; Wu et al., 2018). Notably, Sec71/Sec72 genes are restricted to fungi and this post-
translation translocation process has been worked out in yeast. A similar process is 
expected to occur in metazoans to a lesser extent, however proteins other than Sec71/72 




Another TPR-containing protein involved in a specialized post-translational 
membrane integration process is small glutamine-rich TPR-containing protein alpha 
(SGTA). SGTA acts as a co-chaperone within a complex of proteins, including BAG6 
and TRC40 (Get3 in yeast), that facilitates the targeting of tail-anchored membrane 
proteins to a Golgi to ER traffic (GET) membrane integration complex in the ER 
membrane, as well as the sorting of membrane and secretory proteins that mislocalize to 
the cytosol for degradation (Martínez-Lumbreras et al., 2018). In combination with the 
BAG6 complex, SGTA helps to perform molecular triage to regulate the fate of tail-
anchored (TA) membrane proteins and mislocalized secretory cargo by binding 
hydrophobic substrates and transferring selected protein clients to the BAG6 complex for 
sorting (Figure 1.3B) (Shao et al., 2017). SGTA is comprised of an N-terminal 
dimerization domain, a central domain consisting of three TPR motifs and a C-terminal 
substrate binding motif (Chartron et al., 2011; Darby et al., 2014; Dutta and Tan, 2008; 
Martínez-Lumbreras et al., 2018; Simon et al., 2013). The TPR domain interacts directly 
with Hsp70 and Hsp90 chaperones, as well as the proteasomal subunit, Rpn13 (Leznicki 
et al., 2015; Minami et al., 2010; Thapaliya et al., 2016). The TPR domain gives SGTA 
the co-chaperone-like ability to participate in both productive “on-pathway” folding as 
well as protein degradation.  
As proteins enter the secretory pathway, they are assessed by a number of ER 
resident quality control factors to determine if they are properly folded or require 
additional folding attempts (Ellgaard and Helenius, 2003; Tannous et al., 2015). If a 
protein is deemed terminally misfolded, it is targeted for ERAD, which requires retro-




degradation by the proteasome. SEL1L co-localizes with HRD1, one of the ER E3 ligases 
involved in ERAD (Gardner et al., 2000). It also associates with additional ERAD factors 
including OS-9 and GRP94 (the ER Hsp90) that have been shown to deliver mutant 1-
antitrypsin to the HRD1-SEL1L ubiquitin complex for degradation, confirming its role in 
ERAD (Figure 1.3C) (Christianson et al., 2008). 
The recently solved structure of SEL1L provides insight into how it contributes to 
the ERAD process (Jeong et al., 2016). SEL1L is comprised of a fibronectin type II 
domain at the N-terminus followed by eleven SEL1L-like repeat (SLR) motifs and a C-
terminal transmembrane domain (Figure 1.2). The SLR motif shares a similar anti-
parallel -helical structure with the TPR motif, but the consensus sequence length is 
extended (36-44 amino acids compared to 34) (Mittl and Schneider-Brachert, 2007). 
Studies on SEL1L from mus musculus show that the SLR motifs make up the major 
portion of the luminal domain of SEL1L and are isolated into three clusters consisting of 
4 SLRs (SLR-N(terminal) includes repeats #1-4), 5 SLRs (SLR-M(12dle) repeats #5-9) 
and 2 SLRs (SLR-C(terminal) repeats #10 and 11). SLR #9 of the SLR-M domain was 
shown to be required for the homo-oligomerization of SEL1L (Jeong et al., 2016). The 
SLR-C domain is responsible for mediating the interaction with a luminal portion of 
HRD1. Additionally, in yeast, SLR-C has been shown to mediate interactions with Yos9 
(OS-9 homologue) as truncation mutants in Hrd3p (the SEL1L homologue) lacking this 
region were no longer able to bind Yos9 (Figure 1.3C) (Gauss et al., 2006). The N-
terminal cluster contains 4 motifs and sequence analysis suggests that it may bind a 
specific partner or act as a classic co-chaperone (D’Andrea and Regan, 2003). The SLR 




formation with other ERAD components; however, the role of the N-terminal SLR 
domain is still unknown.  
Together, TPR and SLR-domain containing proteins aid in nucleating interactions 
at the ER membrane that support the translocation of proteins into and out of the ER 
lumen. The TPR domains in Sec72 and SGTA both recruit Hsp70/Hsp90 chaperones to 
complexes that mediate targeting of proteins to the ER for quality control, therefore 
promoting efficient organization of specific substrates and productive folding. The SLR 
domains of SEL1L contribute to multi-protein complex formation and recruitment of 
necessary ERAD factors so that terminally misfolded proteins do not accumulate, 
maintaining cellular protein homeostasis in a complex environment. 
1.3.2 Molecular chaperone adapters and regulators 
A main role for TPR-containing proteins in the cell is nucleating chaperone 
macromolecular complexes and regulating their activity (Brehme et al., 2014; Caplan, 
2003). Hsp70 and Hsp90 are major molecular chaperones in the eukaryotic cytosol, 
playing essential roles in protein quality control by preventing aggregation, catalyzing 
productive folding of newly synthesized proteins and promoting degradation of misfolded 
polypeptides (Hartl et al., 2011; Hideaki and Yohtalou, 1991). Co-chaperones of Hsp70 
and Hsp90 are characterized as non-client binding partners that participate in their 
function and regulation (Caplan, 2003). Hsp70 and Hsp90 cooperate with co-chaperones 
during the process of protein folding and require the help of co-chaperones containing 
TPR motifs for many of their functions. Isoforms of Hsp70 and Hsp90 exist within the 
different organelles, often performing similar functions. The ER contains both Hsp70 and 




been shown to localize to both the rough and smooth ER as they are some of the most 
abundant proteins within the organelle, participating in quality control, productive folding 
and stress response. As such, they are often recruited to sub-regions of the ER by co-
chaperones dictating their role in maintaining protein homeostasis and one of the co-
chaperones contains TPRs (discussed below). 
To better understand how TPR-containing proteins act as co-chaperones, we first 
describe cytosolic TPR-containing proteins because their roles as co-chaperones have 
been extensively characterized. One of the most well-studied TPR-containing proteins, 
Hsp70/Hsp90 Organizing Protein (HOP), mediates the spatial proximity of Hsp70 and 
Hsp90 by associating with both chaperones and facilitating the passage of cargo from one 
major chaperone to the other for efficient protein folding. HOP is a monomeric protein 
composed of nine TPR motifs, clustered into three distinct TPR domains (Odunuga et al., 
2004; Yi et al., 2010). Both chaperone sequences end with the motif EEVD and this 
tetrapeptide is recognized by the HOP TPR1 and TPR2A domains for Hsp70 and Hsp90, 
respectively. Crystal structures of the TPR-peptide complexes show peptides spanning 
the groove in the concave surface of the TPR domains and binding is mediated by 
electrostatic interactions with the EEVD motif with the C-terminal aspartate acting as a 
two-carboxylate clamp (Figure 1.1B) (Scheufler et al., 2000). The hydrophobic contacts 
between the peptide residues upstream of EEVD and the TPR domain backbone are 
critical for specificity.  
These structural studies gave essential insight into how TPR co-chaperones are 
able to recruit cytosolic Hsp70 and Hsp90 and subsequent studies have identified 




Hsp70 and Hsp90 together, other TPR co-chaperones with a TPR domain for Hsp 
chaperone binding often contain a different domain (i.e. E3 ligase) that targets the Hsp 
chaperone and its bound substrate for a specific process. Additionally, studies identified 
selective binding between chaperone-TPR pairs (Assimon et al., 2015). In vitro studies 
found that the TPR co-chaperones HOP, CHIP and DNAJC7 bound both Hsp70 and 
Hsp90 with similar affinities but co-chaperones FKBP51 and 52 preferably bound Hsp90. 
The intrinsic affinity and post-translational modifications tune the interactions between 
the Hsp70 and Hsp90 proteins and their TPR co-chaperones. Phosphorylation of the 
Hsp70 or Hsp90 C-termini significantly decreased their binding affinity to CHIP. Many 
of the Hsp70 and Hsp90 co-chaperones contain functional domains outside of the TPR 
region that direct the localization or function of their requisite chaperone-TPR pairs, 
which could explain selective binding between these chaperone families and the distinct 
roles they play within the cell. 
Although it is likely that more than 100 co-chaperones exist in mammals, it 
appears that of the ones identified and analyzed, the proteins fall into two classes, those 
that contain a J-domain and those that contain TPR motifs (Caplan, 2003). Erdj6 (also 
known as P58IPK) is an ER resident protein that contains both features (Figure 1.2). The 
crystal structure of human Erdj6 revealed three N-terminal TPR domains, containing 
three TPRs each (similar to that found for HOP), and a C-terminal J-domain (Svärd et al., 
2011). Interestingly, studies in mice show Erdj6 can be found in complex with the ER 
Hsp70 paralog, BiP (Figure 1.4A) (Rutkowski et al., 2007). Evidence of its role in 
secretory protein maturation and quality control was provided when it was found to co-




role for Erdj6 was further supported by the fact that protein maturation was stimulated 
upon its overexpression and knockout cells showed decreased protein synthesis under 
both normal and stressed conditions; and its expression was induced by ER stress 
(Rutkowski et al., 2007; Yan et al., 2002).   
Even though many of the cytosolic TPR co-chaperones interact with the C-
terminal EEVD motif of Hsp70 or Hsp90, Erdj6 most likely binds to BiP via its C-
terminal J-domain. Studies of classic Hsp chaperone systems in bacteria (E. coli) have 
shown that J-domain containing proteins have the ability to affect chaperone substrate 
binding by regulating nucleotide binding (Liberek et al., 1991). Mammalian Erdj6 
contains the critical Hsp70 binding tripeptide motif (HPD) in its C-terminal J-domain 
(Svärd et al., 2011). The N-terminal TPR cluster contains a conserved hydrophobic patch 
that may be involved in binding misfolded polypeptides. This conserved hydrophobic 
patch is 100 Å away from the BiP binding motif in the J-domain and structure-based 
mutagenesis for the conserved hydrophobic residues significantly reduced the molecular 
chaperone activity of Erdj6 (Figure 1.4A) (Tao et al., 2010). A flexible linker between the 
TPR subunits and the J-domain could allow movement suggesting that substrates bound 
to the hydrophobic surface/cleft in the TPR cluster could be brought to BiP bound at the 
C-terminal end (Svärd et al., 2011). Additionally, mouse Erdj6 constructs lacking the J-
domain expressed in cells still bind misfolded substrate, suggesting that the N-terminal 
TPR motifs can bind polypeptides (Petrova et al., 2008).  
As there has been estimated to be over 114 TPR-containing proteins in the 
chaperome (Brehme et al., 2014), it is likely that there are TPR-containing proteins in 




chaperone network in the ER. Among the 114 proteins in the TPR-containing chaperone 
family, two proteins, TTC13 and TTC17, were simultaneously identified by a 
bioinformatic screen we performed for novel secretory adaptor proteins as putative TPR-
containing proteins that are potentially targeted to the ER by an N-terminal signal 
sequence (Figure 1.2). TTC13 remains uncharacterized and a study conducted in 2014 
suggested that TTC17 is involved with actin organization and ciliogenesis in zebrafish 
and humans based on an interaction between TTC17 and C2orf62, which was determined 
using only a small GST-tagged purified region of TTC17 (aa 945-1041), excluding 
TTC17’s N-terminal ER targeting sequence (Bontems et al., 2014). However, our data 
shows that both TTC17 and TTC13 reside within the ER (Figure 3.1 and Appendix A1). 
The function for either protein is not yet understood. Interestingly, the organization of the 
predicted TPR motifs in both proteins indicates that they may act as co-chaperones. 
TTC13 contains seven predicted TPR motifs; one near the N-terminus of the protein 
followed by six consecutive motifs (Figure 1.2) (Karpenahalli et al., 2007). The six 
consecutive motifs are similar to the closely adjacent clusters of three motifs seen in 
Erdj6. TTC17 contains eight predicted TPRs according to TPRPred, one in the N-
terminal portion of TTC17, a cluster of three TPRs in the middle and a cluster of four 
TPRs at the C-terminus. Although TTC17 is much larger than HOP, the two clusters 
could coordinate chaperone spatial organization and activities in a similar manner to 
HOP. Given that many of the ER localized soluble folding factors possess the C-terminal 
ER retention motif, KDEL, it will be of special interest to determine if this sequence, in 




binding to an ER adapter, like TTC13 or TTC17, that might help support ER organization 
and retention. 
1.3.3 Protein modifications 
Protein modifications involve covalent additions to proteins that expands their 
function and regulation (Bürkle, 2001; Truttmann and Ploegh, 2017). Protein 
modifications play fundamental roles in regulating protein folding, targeting, interaction 
with ligands or protein partners, functional states and stability. TPR-containing proteins 
contribute to protein regulation and function through post-translational modification in 
the ER by modifying chaperones with small molecules or by glycosylation (Figure 1.4) 
(Schjoldager and Clausen, 2012; Truttmann and Ploegh, 2017). 
BiP is the ER member of the Hsp70 family and it relies on a number of partners, 
including J-domain co-chaperones (Hsp40 family members), nucleotide exchange factors, 
and signal transducers for its various activities (Dudek et al., 2009; Pobre et al., 2018). 
The activity of BiP is also modulated by AMPylation by the TPR-containing ER protein 
FICD (filamentation-induced by cyclic AMP domain containing protein) (Figure 1.4A) 
(Preissler et al., 2015, 2016a). AMPylation, also known as adenylation, is the process 
whereby adenosine monophosphate (AMP) from an ATP molecule is transferred to either 
a Tyr, Ser or Thr residue on the target protein. AMPylation of eukaryotic proteins is 
intimately related to the presence of FIC domains (Faber et al., 1998). FIC proteins are 
identifiable by their HXFX(D/E)(G/A)N(G/K)RXXR motif, which is the domain 
responsible for AMPylating substrate (Garcia-Pino et al., 2014). FICD, also known as 
Huntingtin interacting protein E (HYPE), is the only FIC-domain containing protein in 




substrate of FICD (Sanyal et al., 2015). FICD expression was upregulated under stress 
conditions and its knockdown prevented induction of the unfolded protein response 
(UPR). BiP is AMPylated at residue Thr518 in the substrate binding domain leading to its 
inactivation (Preissler et al., 2015, 2016b). This modification is reversible as shown by 
the regulatory residue, Glu234, on FICD that switches the AMPylation/de-AMPylation 
reactivity (Preissler et al., 2017). When the cell is under normal homeostatic conditions, 
FICD AMPylates BiP to create an inactive BiP pool. As the UPR is activated, FICD de-
AMPylates BiP so that it may engage unfolded substrate providing a rapid method to 
deploy active chaperones. 
FICD is an ER resident type II membrane protein comprised of an N-terminal 
transmembrane © domain followed by two TPR motifs, a linker region and a C-terminal 
FIC domain (Figure 1.2). The FIC domain exhibits well-conserved structure with Pfam 
canonical four -helical FIC domain structure (Garcia-Pino et al., 2014). Dimerization of 
FICD can occur, leaving both of the FIC domains open for substrate binding and the TPR 
motifs available for protein-protein interactions; however, the interacting partners of the 
TPR domain have yet to be determined (Bunney et al., 2014). FICD’s reversible 
ampylation of BiP contributes to tunable chaperone activation and productive folding. 
Glycosylation, the covalent addition of carbohydrate molecules to a functional 
group on polypeptides, is one of the most abundant and diverse protein modifications 
observed in the cell (Schjoldager and Clausen, 2012). Glycosylation can promote 
favorable folding energetics and lower aggregation propensity to help support proper 
protein folding (Hebert et al., 2014; O’Connor and Imperiali, 1996; Price et al., 2012; 




glycosylation, whereby saccharides are attached either to the amide group of an Asn 
residue (N-linked) or to the hydroxy of Ser or Thr residues (O-linked) (Ecker et al., 
2003). Approximately one third of the mammalian proteome is targeted to the secretory 
pathway, and the majority of these proteins are glycosylated (Apweiler et al., 1999). 
While N-linked glycosylation is the most common modification in the ER, O-
glycosylation also occurs here. Recently, a family of membrane proteins containing long 
stretches of TPR domains was found to be involved in O-mannosylation in the ER. 
O-linked glycosylation takes place in several parts of the cell. The main pathway 
is located in the Golgi, however O-mannosylation begins in the ER. It is catalyzed by ER 
resident protein O-mannosyl transferases most commonly involving POMT1 and POMT2 
(Figure 1.4B) (Ecker et al., 2003). These carbohydrate chain modifications can be used to 
monitor glycoprotein movement through the secretory pathway, acting as a maturation 
and quality control tag to indicate the status of the folding polypeptide in a manner 
similar to that previously observed for N-linked glycans (Hebert et al., 2014; Xu and Ng, 
2015).  
A new class of TPR-containing proteins that localize to the ER has recently been 
revealed: transmembrane TPR-containing proteins (TMTC) 1-4 (Sunryd et al., 2014). 
TMTC1-4 contain homologous structural elements as their N-terminal halves are 
comprised of a number of hydrophobic domains and the C-terminal halves are composed 
mainly of TPR motifs (Figure 1.2). Although the structures for TMTC1-4 have yet to be 
determined, the predictive architecture could be compared to that of the POMT proteins 
and other O-linked transferases (Figure 1.4B). Both TMTC1-4 and POMT1/2 contain 




studies performed on yeast PMT genes, this positions the active site of the transferase 
close to the membrane to potentially enable the efficient transfer of the mannose from the 
dolichol-mannose precursor embedded in the membrane to the substrate (Bai et al., 
2019). In order to attach, modify, or recognize glycoproteins, folding factors and 
machinery often possess multiple substrate recognition motifs or domains mediating 
specificity. In the POMT proteins, three MIR domains, named for the three proteins in 
which they occur (Mannosyltransferase, Inositol 1,4,5-triphosphate receptor (IP3R) and 
Ryanodine receptor), are present on a loop that faces the ER lumen and putatively bind 
substrates or chaperones (Fujimori et al., 2017). In contrast, the TMTC proteins possess 
8-10 consecutive TPR motifs in place of the MIR domains that potentially interact with a 
broad range of target substrates as observed for other O-linked transferases such as O-
linked N-acetylglucosamine (GlcNAc) transferase (OGT). Information on the function of 
the TPRs of OGT may provide the framework for understanding the role of the TPRs in 
the TMTCs. 
OGT resides in the cytoplasm and catalyzes the transfer of GlcNAc from UDP-
GlcNAc to Ser and Thr of cytoplasmic, nuclear and mitochondrial proteins including 
numerous transcription factors, tumor suppressors, kinases, phosphatases and histone-
modifying proteins (Shafi et al., 2000; Yang et al., 2002). OGT contains an N-terminal 
domain comprised of 12.5 TPRs that mediates the recognition of a broad range of target 
proteins, as well as a C-terminal glycosyltransferase domain (Iyer and Hart, 2003; Lubas 
et al., 1997). The crystal structure of the homodimeric TPR domain of OGT, containing 
11.5 of the consecutive TPR motifs, displays an elongated superhelical structure (Figure 




manner reminiscent of the peptide binding site of importin-, suggesting that this helical 
structure might help select and recruit substrates for modification (Figure 1.1C, right 
panel). Therefore, it would follow that the TPR domains of TMTC1-4 might also be used 
for substrate selection and positioning. TMTC1-4 have been implicated in the O-
mannosylation of the cadherin family of proteins as their knockout shows a significant 
reduction in the number of modified O-mannosylated sites within this family of proteins 
(Larsen et al., 2017a). However, active sites and direct transfer of O-mannose from the 
TMTCs to cadherins as well as interactions between the TMTCs and these proteins has 
yet to be determined. With further characterization, it will be of interest to determine if 
the TPR domains of TMTC1-4 can specifically bind the repeat domains of cadherins. 
Though similar in composition, TMTC1-4 may play varying roles within the ER 
as they are associated with unique disease phenotypes. Interestingly, TMTC3 is 
implicated in two diseases that appear to involve O-linked glycosylation. Biallelic 
mutations in human TMTC3 are associated with recessive forms of cobblestone 
lissencephaly (COB), a severe brain malformation due to the over-migration of neurons 
and glial cells (Jerber et al., 2016). The cause of the over-migration defect is impaired 
interaction between glial limitans and the extracellular matrix (ECM), which is dependent 
upon glycosylated cell surface proteins making physical linkages between the 
cytoskeleton of glial cells and the ECM. Coincidentally, heterozygous variants of TMTC3 
were also identified in periventricular nodular heterotopia (PVNH), another disease 
resulting in defects in neuronal migration shown to cause brain malformations (Farhan et 
al., 2017). Expression analysis in patient-derived cells confirmed reduced transcript and 




increased susceptibility to induced seizures. This phenotype was rescued by neuron-
specific expression of human TMTC3, suggesting a role for TMTC3 in synaptic cells and 
seizure biology.  
A mutation in TMTC2 (Val381Ile) is linked to nonsyndromic sensorineural 
hearing loss (SNHL) (Runge et al., 2016). Exome sequencing, lineage and association 
analyses identified a fully penetrant sequence variant in the TMTC2 gene region that is 
associated with SNHL in a nine-family member cohort. This same variant was then found 
in a group of 363 unrelated individuals and associated with SNHL. TMTC4 was also 
linked to hearing loss in mice as tmtc4 inactivation in the cochlea caused acquired 
postnatal hearing loss (Li et al., 2018). After demonstrating a direct link between the 
more common noise-induced hearing loss (NIHL) and the UPR, mice with homozygous 
inactivation of both Tmtc4 and Chop had less hearing loss than knockout of Tmtc4 alone 
using inverse genetic complementation. 
Post-translational modifications frequently affect protein function via changes in 
the protein structure and dynamics (Li et al., 2010). Post-translational modifications 
participate in a number of roles such as gene expression regulation, mediation of protein-
protein interactions and, as demonstrated above by ER TPR-containing proteins, 
activation or deactivation of enzymatic activities or protein stability or destruction. As 
modulators of cell signaling and regulation, they perform a crucial role in maintaining 
cellular homeostasis. Diseases linked to post-translational modifications often involve 
mutations of post-translational target sites, however, as exhibited above, diseases can 
result from mutations in the protein modifiers themselves (Jerber et al., 2016; Lazarus et 




sites as well as TPR region result in disease (Jerber et al., 2016; Lazarus et al., 2011; 
Pravata et al., 2019). 
1.3.4 Regulation of ER calcium homeostasis 
Intracellular calcium is a universal second messenger in mammalian cells and 
chronic changes in Ca2+ signaling contribute to the pathogenesis of many diseases (Glaser 
et al., 2018). Ca2+ concentrations vary within the cell (10-100 nM) generally being lowest 
in the cytoplasm. One of the major functions of the smooth ER is calcium storage and it 
contains a host of factors dedicated to sensing and regulating intracellular calcium 
concentrations communicating with the cytoplasm, mitochondria and extracellular 
environment through the plasma membrane to maintain homeostasis (Lunz et al., 2019). 
The ER is also able to release stored Ca2+ through the ER resident IP3 and ryanodine 
receptors and upon depletion, the ER Ca2+ re-uptake channel, SERCA, can refill the 
depleted stores. TPR-containing proteins have been shown to alter cytoplasmic calcium 
levels by interacting with and modulating the activity of SERCA (Sunryd et al., 2014). 
TMTC1, TMTC2 and TMTC4 were identified and characterized as ER-localized, 
transmembrane proteins involved in calcium homeostasis (Li et al., 2018; Sunryd et al., 
2014). They interact with the calcium re-uptake channel, SERCA2B, while TMTC2 and 
TMTC4 also bound the carbohydrate binding chaperone, calnexin. TMTC1, 2 and 4 
regulate the ability of SERCA to sequester Ca2+ back into the ER after stimulated Ca2+ 
release. Live cell Ca2+ measurements revealed that overexpression of either TMTC1 or 2 
caused a reduction of Ca2+ present in the cytoplasm following stimulation suggesting 
increased retention or re-uptake, whereas knockdown of either or deletion of TMTC4 




TMTC2 is differentially expressed in patients receiving serotonin re-uptake inhibitor 
(SSRIs) treatment for depression over the course of eight weeks (Madsen et al., 2018). 
TMTC2 was among other genes involved in calcium homeostasis that were shown to 
significantly increase with time and subsequent SSRI treatment. It will be of interest to 
determine if O-mannosylation plays a role in calcium regulation by direct modification of 
SERCA2B. 
1.4 Summary 
The ER utilizes protein-protein interaction motifs to efficiently execute various 
roles to maintain cellular homeostasis in a large single luminal space and a contiguous 
membrane. In particular, the presence of TPR motifs provides binding specificity for 
subsets of interactors while domains outside of the TPRs mediate activity. Thus far, ER 
TPR- or TPR-like containing proteins contribute to protein translocation both into and out 
of the ER membrane, post-translational modification and act as co-chaperones. Eleven 
proteins, with tandem arrays from 2-10 sequential TPRs, have been identified that 
associate with or are localized within the ER. Interestingly, the presence of TPR motifs 
has become increasingly easier to predict using algorithms (Letunic and Bork, 2018), but 
the structures of the ER TPR-containing proteins are poorly understood, and oftentimes 
the function of the protein is identified prior to structure. Further studies using super 
resolution microscopy and proteomics are critical to provide a better understanding of the 
localization and identifying interacting partners of the ER TPR-containing proteins. 
Given that the ER is involved in maintaining cellular protein, calcium and lipid 
homeostasis, it would be of interest to explore other families of repeat proteins, such as 




contribute to ER morphology, organization and function. Coiled-coil domain containing 
proteins have previously been shown to contribute to ER membrane curvature and shape. 
The integral membrane protein Climp-63, which localizes exclusively in sheets, is 
thought to use its luminal coiled-coil domain to bridge between two apposed membranes 
(Klopfenstein et al., 2001). Additionally, the surface of ER sheets is kept flattened, likely 
by the sheet-enriched integral membrane proteins kinectin and p180, which possess a 
cytosolic coiled-coil domain that may form rod-like scaffolds (Shibata et al., 2010). WD-
40 repeat containing protein, Sec13p, is involved in ER cargo export and ankyrin repeat 
containing ASB11 is a novel ER-associated ubiquitin ligase (Andresen et al., 2014; 
Barlowe, 1998). There are also other protein domains, such as intrinsically disordered 
regions (IDRs) (i.e. in SEL1L, FICD and TMTC3) or Proline-rich regions (i.e. in SEL1L) 
predicted to be present in some of the ER TPR-containing proteins, which could 
contribute to essential interactions and function. Macromolecular complexes mediate 
many essential cellular processes. Key to understanding their mechanisms is knowing 
how these macromolecular assemblies are held together, localized and recruit substrates, 








Figure 1.1. Tetratricopeptide Repeats. (A) A single tetratricopeptide repeat (TPR) motif 




are found in multiple organisms and all organelles within the cell. TPR motifs are known 
to mediate protein-protein interactions in multi-protein complexes and are most often 
found in clusters of 3 or more to form a functional domain. (B) The crystal structure 
(1ELR) represents the TPR domain found in Hsp70/Hsp90 Organizing Protein (HOP), 
which binds to the chaperone Hsp90. The single TPR motifs are indicated in red, orange 
and yellow, with the C-terminal capping helix in turquoise. The C-terminal pentamer of 
Hsp90, which is the ligand for this cluster, is shown in blue. (C) The crystal structure 
(1W3B) represents the TPR region of OGT. It forms a superhelix with individual motifs 
indicated in pink, purple, brick red, red, orange, yellow, green, periwinkle, blue and 
violet from N-terminus to C-terminus, respectively. The structure in the right panel is the 
11.5 TPR motifs from left panel rotated 90 degrees, which demonstrates the superhelical 
nature of the tandem repeats. Conserved Asn (red spheres), thought to mediate target 







Figure 1.2. ER TPR-containing proteins. Nine TPR-containing proteins have been shown 
to localize to the ER. N-terminal signal sequences (black squares) target these proteins to 
the ER and the names, positions of tetratricopeptide repeats (TPRs) (orange squares) and 
hydrophobic domains (blue squares) are designated. SEL1L has a fibronectin-like type II 
domain at its N-terminus indicated in green. Erdj6’s J-domain (magenta rectangle) and 








Figure 1.3. Sec72, SGTA and SEL1L are involved ER protein translocation. (A) Sec72 




Sec61 (purple) translocon. The TPR domain, comprised of three TPR motifs (orange 
hexagons), binds the C-terminus of the yeast Hsp70 (blue), Ssa1, aiding in the 
recruitment of translated polypeptides to the Sec61 translocon. (B) SGTA (orange) aids 
in post-translational translocation, specifically of tail-anchored proteins. SGTA is 
comprised of an N-terminal UBL-binding domain, which is also responsible for homo-
dimerization, a middle TPR domain and C-terminal substrate binding domain that 
captures the tail-anchored proteins (light grey). SGTA is in a complex with UBL4A and 
Bag6 (dark and light green, respectively) and plays a role in molecular triage. This 
complex is responsible for the proper targeting of tail-anchored proteins to the ER 
membrane as well as segregating misfolded polypeptides and targeting them for 
degradation. As chaperones aid in this process, SGTA’s TPR domain is responsible for 
chaperone recruitment. The TPRs bind the C-termini of both Hsp70 and Hsp90 as well as 
proteasomal subunit, Rpn13. (C) As nascent polypeptides are queried for folding status, 
properly folded proteins are distinguished for export at ER exit sites (ERES) and 
misfolded proteins are targeted for degradation by ERAD. SEL1L (orange) is in complex 
with Hrd1, the ER retrotranslocon responsible for translocating misfolded proteins across 
the ER membrane for subsequent degradation by the proteasome (yellow) in the 
cytoplasm. SEL1L contains 11 SLR motifs (hexagon #1-11 from N to C-terminus), which 
are very similar to TPR motifs but with an extended consensus sequence length, that 
comprise the majority of the luminal portion of the protein. The SLR motifs nearest the 
membrane (#10-11) interact with a luminal portion of Hrd1 and are necessary for 
interaction with ERAD factor, OS9 (brown). A TPR motif in the middle region (#9) is 









Figure 1.4. ER TPR co-chaperone, Erdj6, and protein modifiers, FICD and TMTC1-4 
control protein homeostasis through interactions with BiP and glycosylation. (A) Erdj6 




rectangles). The J-domain contains an Hsp70 interaction motif, HPD, and modulates the 
nucleotide binding activity of the ER Hsp70, BiP (gradient blue). The N-terminal TPR 
domain of Erdj6 can bind exposed hydrophobics on folding polypeptides (red) and 
potentially pass them off or sequester them for BiP bound at the J-domain. FICD is 
comprised of 2 N-terminal TPR motifs (orange hexagons) and a C-terminal FIC domain 
(yellow), which is responsible for regulating BiP chaperone activity by AMPylating BiP 
on its substrate binding domain. FICD forms a homodimer mediated through the FIC 
domain and AMPylates BiP under normal conditions to create an inactive BiP pool. As 
the UPR is activated, FICD de-AMPylates BiP so that it may engage unfolded substrate 
(red). (B) TMTC1-4 (blue and orange) are implicated in O-mannosylation. The TMTCs 
are composed of N-terminal hydrophobic domains (blue) embedding them in the ER 
membrane and 8-10 consecutive C-terminal TPR motifs (orange hexagons). POMT1 and 
2 are the known protein O-mannosyl transferases of the ER. They are composed of a 
number of transmembrane domains represented by the light blue hexagon and contain 3 
MIR domains (pink) in a luminal loop. The MIR domains are thought to recruit substrate 
to the membrane so that O-mannosyl transferases can transfer a mannose (green circle) 







TMTC3 CONTRIBUTES TO O-MANNOSYLATION OF E-CADHERIN 
2.1 Abstract 
Protein glycosylation plays essential roles in protein structure, stability and 
activity such as cell adhesion. The cadherin superfamily of adhesion molecules carry O-
linked mannose glycans at conserved sites and it was recently demonstrated that the 
TMTC1-4 genes contribute to the addition of these O-linked mannoses. Here, 
biochemical, cell biological and organismal analysis was used to determine that TMTC3 
supports the O-mannosylation of E-cadherin, cellular adhesion and embryonic 
gastrulation. Using genetically engineered cells lacking all four TMTC genes, 
overexpression of TMTC3 rescued O-linked glycosylation of E-cadherin and cell 
adherence. Knockdown of the Tmtcs in Xenopus laevis embryos caused a delay in 
gastrulation that was rescued by the addition of human TMTC3. Mutations in TMTC3 
have been linked to neuronal cell migration diseases including Cobblestone 
lissencephaly. Analysis of TMTC3 mutations associated with Cobblestone lissencephaly 
found that three of the variants exhibit reduced stability and missence mutations were 
unable to complement TMTC3 rescue of gastrulation in Xenopus embryo development. 
Our study demonstrates that TMTC3 regulates O-linked glycosylation and cadherin-
mediated adherence, providing insight into its effect on cellular adherence and migration, 
as well the basis of TMTC3-associated Cobblestone lissencephaly. 
2.2 Introduction 
Protein glycosylation is the most common and diverse co/post-translational 




structural and biophysical roles in the cell (Apweiler et al., 1999; Hebert et al., 2014; 
O’Connor and Imperiali, 1996; Price et al., 2012; Solá and Griebenow, 2009; Varki and 
Sharon, 2009). There are two general types of glycosylation that are categorized by the 
type of bond used to covalently attach the carbohydrate to the protein (Imperiali and 
Hendrickson, 1995; Jayaprakash and Surolia, 2017). N- and O-linked glycans are 
attached to proteins through N-glycosidic (Asn) or O-glycosidic (Ser/Thr) bonds, 
respectively. A third of the proteome is targeted to the secretory pathway in eukaryotic 
cells where both N- and O-linked modifications are commonly observed. The 
endoplasmic reticulum (ER) serves as the entry portal for secretory pathway cargo. The 
majority of the proteins in the ER are modified by N-linked glycans; however, a 
restricted fraction is modified by O-linked glycans (Apweiler et al., 1999; Vester-
Christensen et al., 2013).   
A diverse set of O-glycans are added in the ER that include mannose, fucose, 
glucose or N-acetyl glucosamine (Joshi et al., 2018). O-mannosylation is conserved from 
fungi to mammals. It is initiated by the transfer of a mannose saccharide from a donor 
dolichol P-mannose substrate embedded in the ER membrane to a Ser/Thr on the target 
protein (Bause and Lehle, 1979). This transfer is catalyzed by ER resident protein O-
mannosyl transferases most commonly involving POMT1 and POMT2 with -
dystroglycan as the main substrate in mammals, and Pmt1-7 in yeast (Guerreiro et al., 
1996; Immervoll et al., 1995; Lussier et al., 1995; Strahl-Bolsinger et al., 1993; Wing et 
al., 1992). Their general architecture is that of large polytopic membrane proteins, which 
display variations of a diacidic motif (i.e. Asp-Glu) in the first luminal loop region 




Mushegian, 2003; Loibl and Strahl, 2013). Metazoan and yeast O-mannosyltransferases 
also contain conserved Mannosyltransferase, Inositol triphosphate and Ryanodine 
receptor (MIR) domains. MIR domains have been shown to be essential for enzymatic 
activity in yeast and have been implicated in substrate binding based on studies 
performed on other mammalian MIR domain containing proteins such as SDF2 (Fujimori 
et al., 2017; Girrbach et al., 2000; Lommel et al., 2011; Meunier et al., 2002; Ponting, 
2000).  
A new putative family of O-mannosyl transferases was recently discovered in 
mammals (Larsen et al., 2017a, 2017b). This family is comprised of four tetratricopeptide 
repeat (TPR)-containing proteins that appear to be ER polytopic transmembrane proteins 
called TMTC1-4 (transmembrane and TPR-containing proteins 1-4)(Cao et al., 2012; 
Della-Morte et al., 2011; Larsen et al., 2017a; Li et al., 2018; Racapé et al., 2011; Sunryd 
et al., 2014). TMTC1, 2 and 4 are ER proteins involved in Ca2+ regulation as they 
associate with ER Ca2+ re-uptake pump SERCA2B (Li et al., 2018; Sunryd et al., 2014). 
The knockouts of TMTC1-4 have been shown using glycoproteomics to be involved in 
the O-mannosylation of cadherins (Larsen et al., 2017a, 2019). TMTC1-4 contain 
homologous structural elements as their N-terminal halves are comprised of a number of 
hydrophobic domains and the C-terminal halves are predicted to be composed mainly of 
long stretches of TPR motifs (8-12) (Figure 2.1A) (Karpenahalli et al., 2007; Letunic and 
Bork, 2018). Two of the TMTCs, TMTC3 and TMTC4, contain putative diacidic motifs 
(Asp-Asp or Glu-Glu) on N-terminal luminal loops based on predictive topology, making 
them appear homologous to the POMTs and Pmts (Figure 2.4B) (Bai et al., 2019; Hessa 




TPRs are protein structural motifs that support protein-protein interactions and are 
frequently found on co-chaperones (Brehme et al., 2014; Magliery and Regan, 2005). A 
single TPR motif consists of a degenerate 34-amino acid sequence that is comprised of 
two anti-parallel -helices (Figure 1.1A) (D’Andrea and Regan, 2003; Magliery and 
Regan, 2005). TPR domains are most commonly found in a cluster of three TPR motifs; 
however, clusters comprised of up to sixteen sequential TPRs have been observed 
(D’Andrea and Regan, 2003). Proteins with three TPRs in a cluster favor the recognition 
of short and defined sequences, whereas proteins with long stretches of consecutive TPRs 
tend to be more promiscuous in their selectivity. Unlike classic TPR co-chaperones, 
which contain three to four consecutive motifs, the composition of TMTC1-4, with eight 
to twelve consecutive motifs, is similar to that of the well-studied TPR-containing 
cytoplasmic O-GlcNAc transferase (OGT), which contains a stretch of 12.5 TPRs 
followed by a C-terminal catalytic domain (Jínek et al., 2004; Lazarus et al., 2011). The 
structure of OGT reveals that the TPRs form a super helix responsible for 
homodimerization of OGT and are proposed to scaffold interactions with other proteins, 
potentially playing a role in substrate selectivity (Figure 1.1C). Dimerization of the TPR 
domain is mediated by the convex faces of the superhelical monomers, and the concave 
surface contains conserved Asn, which form a continuous ladder (Figure 1.1C right 
panel). This Asn conservation is similarly observed in the ARM-repeat proteins importin-
 and -catenin (Conti et al., 1998; Huber and Weis, 2001). The Asn in these proteins 
contribute to binding of a target peptide (nuclear localization sequence with importin- 
and E-cadherin with -catenin), suggesting that the TMTCs may use a similar mechanism 




Mutations in the TMTC genes have been linked to various human disease states 
(Farhan et al., 2017; Jerber et al., 2016; Li et al., 2018; Runge et al., 2016). Point 
mutations in human TMTC2 and the knockout of Tmtc4 in mice result in hearing loss 
(Guillen‐Ahlers et al., 2018; Li et al., 2018; Runge et al., 2016). Ten mutations in 
TMTC3 are associated with neuronal cell migration diseases (Farhan et al., 2017; Jerber 
et al., 2016). Biallelic mutations resulting in single amino acid or frame shift changes in 
TMTC3 were identified in a cohort of families with recessive forms of Cobblestone 
lissencephaly, a severe brain malformation in which over migration of neurons and glial 
cells results in the formation of cortical dysplasia, or brain development abnormalities 
(Jerber et al., 2016). Another study identified heterozygous variants of TMTC3 in 
patients with periventricular nodular heterotopia (PVNH), a common brain malformation 
caused by the failure of neurons to migrate from the ventricular zone to the cortex 
(Farhan et al., 2017). While mutation or loss of the TMTC genes has been associated with 
a number of diseases, an understanding of how these mutations result in specific defects 
is unclear. 
Here, in silico, biochemical, cell and developmental biological approaches were 
used to expand our understanding of the organization, localization, activity and function 
of TMTC3 and TMTC4. Previously uncharacterized TMTC3 and 4 were identified as ER 
TPR-containing membrane proteins with their TPR domains orientated within the ER 
lumen. Using TMTC HEK293 knockout cells, it was demonstrated that TMTC3 
complementation recovered the O-mannosylation of E-cadherin. While the knockout of 
the TMTCs did not affect the stability, localization or trafficking of E-cadherin, it did 




adherence, specifically E-cadherin mediated adherence. Subsequent analysis of protein 
O-mannosyltransferase protein architecture showed that TMTC3 shares functional 
similarity with O-mannosyltransferases (POMT1/2 and Pmt1-7) as it contains two 
diacidic motifs (Asp-Asp and Glu-Glu) located in a putative N-terminal luminal loop and 
mutation of the Asp-Asp motif results in reduced TMTC3 stability. Additionally, the 
knockdown of Tmtc3 and Tmtc4 in Xenopus laevis resulted in an embryonic gastrulation 
delay phenotype and the delay was rescued by human TMTC3. There are eight disease 
variants of TMTC3 recently associated with Cobblestone lissencephaly and two 
associated with PVNH (Farhan et al., 2017; Jerber et al., 2016). While novel biochemical 
characterization of eight of these disease variants showed that they all localize to the ER, 
three of them are less stable than wild type (WT) and none of missense mutations are able 
to rescue the delay in gastrulation caused by the knockdown of Tmtc3 in Xenopus laevis. 
The identification of TMTC3’s role in O-glycosylation of E-cadherin in combination 
with its knockdown in Xenopus embryos provides further insight into the role O-
glycosylation plays in cell-cell adhesion and migration, and the etiology of Cobblestone 
lissencephaly caused by TMTC3 mutation. 
2.3 Results 
2.3.1 TMTC3 and TMTC4 are ER resident proteins. 
In silico analysis, using SignalP4.0, TargetP1.1, ΔG, TPRPred and domain 
architecture database SMART7, indicated that TMTC3 (NCBI Accession # 
NP_861448.2. (http://www.ncbi.nlm.nih.gov/protein/NP_861448.2)) and TMTC4 (NCBI 
Accession # NP_001073137.1 (http://www.ncbi.nlm.nih.gov/protein/NP_001073137)) 




and eleven and eight C-terminal TPR motifs, respectively (Figure 2.1A) (Emanuelsson et 
al., 2000; Hessa et al., 2007; Karpenahalli et al., 2007; Letunic and Bork, 2018; Nielsen, 
2017; Nielsen et al., 1997, 2019). TMTC3 and TMTC4 cDNAs were subcloned into 
mammalian expression vectors encoding a C-terminal S-tag, and their cellular 
localization was determined by glycosylation assay and confocal immunofluorescence 
microscopy. Secretory proteins are commonly modified in the ER with N-linked glycans 
at the consensus site Asn-Xxx-Ser/Thr. TMTC3 and TMTC4 possess five and three 
predicted N-linked glycosylation consensus sites, respectively (Figure 2.1A), therefore a 
glycosylation assay was used to further analyze ER targeting and localization (Gupta, 
2002). As the molecular weight of an N-linked glycan is ~2.5 kDa, the removal of N-
linked glycans by glycosidase treatment results in a corresponding increase in mobility 
for the deglycosylated protein. Endoglycosidase H (Endo H) trims the high mannose 
glycans encountered in the ER while Peptide-N-Glycosidase F (PNGase F) removes 
complex glycans acquired in the Golgi in addition to high mannose glycans.  
HEK293T cells were transfected with TMTC3 or TMTC4 containing C-terminal 
S-tags. Cell lysate and media fractions were affinity precipitated with S-protein agarose 
beads followed by glycosidase treatment. Shifts upon PNGaseF treatment (Figure 2.1B, 
lanes 9 and 15) were observed for both TMTC3 and TMTC4 demonstrating that both 
proteins were targeted to the ER and received N-linked glycans. A similar increase in 
mobility was observed upon Endo H treatment (Figure 2.1B, lanes 8 and 14) indicating 
that the carbohydrates were high mannose glycoforms suggesting that TMTC3 and 




COS7 cells were transfected with either TMTC3 S-tag or TMTC4 S-tag as COS7 
cells are highly amenable to imaging. Immunofluorescence staining of TMTC3 and 
TMTC4 was compared against an ER (ERp57) or Golgi (GM130) marker (Figure 2.1C). 
Both TMTC3 and TMTC4 co-localized with Erp57, while co-localization was not 
observed with GM130 (Figure 2.1C). Therefore, the glycosylation profiles for TMTC3 
and TMTC4 and the cellular distribution are consistent with TMTC3 and TMTC4 
residing in the ER.  
2.3.2 TMTC3 and TMTC4 are ER membrane proteins with luminal orientated TPR 
motifs. 
Analysis of the TMTC3 and TMTC4 protein sequences with ΔG prediction 
demonstrated that they contained ten and twelve hydrophobic segments, respectively, that 
could potentially serve as transmembrane domains to create polytopic membrane proteins 
(Figure 2.1A) (Hessa et al., 2007). Alkaline extraction of membrane fractions was 
performed to separate membrane and soluble forms of proteins following centrifugation 
to determine if TMTC3 and TMTC4 are integral membrane proteins (Mostov et al., 
1981).  
HEK293T cells were transfected with either TMTC3 or TMTC4 S-tag, and 
proteins were radiolabeled with [35S]-Met/Cys for 1 hr. Cells were homogenized in 
isotonic buffer and fractions were separated by centrifugations. TMTC3 and TMTC4 
were found in the nuclear (N) and total membrane (TM) fractions (Figure 2.2A, lanes 2 
and 4). The nuclear localization of TMTC3 and TMTC4 is likely explained by the 
contiguous nature of the ER and nuclear membrane prohibiting their separation as the ER 




of the total membrane fractions followed by centrifugation found TMTC3 and TMTC4 
exclusively in the membrane pellet (P) (Figure 2.2A, lane 6). This profile was observed 
for the ER membrane protein, calnexin, and not its soluble paralogue calreticulin, which 
largely accumulated in the supernatant (S) (Figure 2.2A, lane 5). Therefore, both TMTC3 
and TMTC4 are integral membrane proteins.  
Since TMTC3 and TMTC4 are membrane proteins, a trypsin protection assay was 
employed to determine if their C-terminal TPR motifs are positioned in the ER lumen or 
the cytoplasm. HEK293T cells were transfected with either TMTC3 or TMTC4 
constructs containing C-terminal S-tags, and cells were homogenized prior to isolation of 
ER-enriched microsomes. Isolated microsomes were resuspended in an isotonic buffer, 
and aliquots were treated with triton X-100 and trypsin as indicated. Trypsin treatment 
produced a discrete TMTC3 fragment of ~83.5 kDa and TMTC4 fragments of ~67.8 and 
57.1 kDa (Figure 2.2B, compare lanes 5 to 6 and 9 to 10). As the TPR domains and S-
tags are both at the C-termini, this demonstrated that the TPR domains of TMTC3 and 
TMTC4 were positioned in the ER lumen (Figure 2.2C). Combined with the modification 
of the glycosylation sites added to the TPR rich regions (Figure 2.1B), these results 
demonstrated that the TPR motifs for both of the membrane proteins, TMTC3 and 
TMTC4, were facing the ER lumen. 
2.3.3 TMTC3 and TMTC4 are upregulated by folding and trafficking stress. 
To compare TMTC3 and 4 to known O-mannosyltransferases, the basal mRNA 
levels of the two classes of proteins were examined. TMTC1-4 and POMT1/2 mRNAs 
were similarly expressed with TMTC4 and POMT1 showing the highest levels at ~2.5% 




less expressed than the ER resident chaperone, BiP, which is ~20% of -actin (Figure 
2.3A).  
Proteins that reside in the secretory pathway are frequently transcriptionally 
upregulated by stress (Walter and Ron, 2011). To determine whether the TMTC3 and 
TMTC4 genes are transcriptionally regulated by ER stress, HEK293A cells were exposed 
to different ER stress conditions. Cells were subjected to N-glycan synthesis inhibition 
(tunicamycin), calcium depletion (thapsigargin), redox stress (dithiotreitol, DTT), 
inhibition of anterograde protein trafficking (brefeldin A) or proteasomal inhibition 
(MG132). RNA was harvested from cells followed by reverse transcription to generate 
cDNA and changes in gene expression were measured by qRT-PCR.  
TMTC3 gene expression was increased with thapsigargin and brefeldin A 
treatment by ~2.1 and 2.5-fold, respectively (Figure 2.3B). TMTC4 gene expression was 
increased with tunicamycin treatment by 1.8-fold and 1.5-fold with brefeldin A treatment 
(Figure 2.3B). Thapsigargin, DTT and MG132 did not produce a significant increase in 
gene expression of TMTC3, although the transcription of BiP was stimulated by all 
treatments. Interestingly, POMT1 and 2 were up-regulated by a number of stresses, 
including a 2-fold increase by tunicamycin (POMT1), and a 2- and 2.5-fold increase by 
thapsigargin for POMT1 and 2, respectively. Both POMT1 and 2 were up-regulated by 
brefeldin A treatment, 2.3 and 2.8-fold, respectively. POMT1 was also up-regulated 1.4-
fold by redox stress. Out of the TMTCs, TMTC4 was up-regulated by stress most 
significantly and POMT1 exhibited similar up-regulation in response to stress, which may 
correspond to their basal mRNA levels being higher or UPR induction upon their 




2.3.4 TMTC3 rescues O-mannosylation of E-cadherin 
TMTC1, TMTC2 and TMTC4 have been shown to associate with SERCA2B and 
play a role in calcium regulation (Li et al., 2018; Sunryd et al., 2014). To investigate the 
cellular role of TMTC3, initially its binding to SERCA2B was tested. HEK293T cells 
were transfected with either TMTC1, TMTC2, TMTC3 or TMTC4 cDNA. Upon cell 
homogenization and total membrane isolation, the TMTCs were affinity purified, and 
associated proteins were resolved by SDS-PAGE. Binding to SERCA2B was monitored 
by immunoblotting (Figure 2.5A). As previously shown, TMTC1, TMTC2 and TMTC4 
associated with SERCA2B; however, no interaction between TMTC3 and SERCA2B 
was observed (Figure 2.5A, lane 9). Therefore, unlike the other TMTCs, TMTC3 does 
not appear to associate with SERCA2B or be involved in calcium regulation. 
 TMTC1-4 were discovered to contribute to the O-mannosylation proteome when a 
subset of substrates remained O-mannosylated in cells that lacked the known O-
mannosyltransferases, POMT1 and POMT2 (Larsen et al., 2017a, 2017b). A significant 
difference in O-mannosylation of the cadherin family of proteins was observed upon 
knockout of all four TMTCs in HEK293 cells (HEK293 quadruple knockout cells 
(TMTC1/2/3/4-/-)) (Larsen et al., 2017a). Glycoproteomics was used to determine that E-
cadherin was O-mannosylated at nine sites (Figure 2.4A). These results were obtained 
using HEK293 cells also lacking COSMC and POMGnT1. COSMC is an essential 
chaperone to T-synthase that modifies glycoproteins with an O-GalNAc linked 
saccharide, and POMGnT1 is a glycosyltransferase that appends 1,2-GlcNAc to O-




COSMC/POMGnT1-/- cells created truncated, more homogenous O-mannosylated 
modifications amenable for glycoproteomics analysis (Vester-Christensen et al., 2013).    
 To assess potential O-mannosyl transferase activity of the individual TMTCs, a 
glycosylation and carbohydrate binding assay was employed in glycosyltransferase 
deficient cell lines including COSMC/POMGnT1/TMTC1/2/3/4-/- HEK293 cells with 
TMTCs complementation (Figure 2.5B). These cells were transfected at similar levels 
individually with S-tagged TMTC1, 2, 3 or 4 (Figure 2.13A). Cell lysates were collected 
and divided into two fractions. One fraction of the lysate was treated with PNGaseF to 
remove N-linked glycans (Figure 2.5B, lane 2) prior to both fractions being affinity 
purified using the lectin, concanavalin A (Con A). Samples were analyzed via SDS-
PAGE and immunoblotted with E-cadherin antisera. 
 E-cadherin levels were not affected by the deletion of COSMC or the 
glycosyltransferases (Figure 2.6A). E-cadherin appears to receive O-linked glycans as it 
was pulled down by Con A even though the glycoproteins lacked N-linked glycans in the 
PNGaseF treated sample (Figure 2.5B, top blot, lane 2). Subsequently, the same assay 
was performed in HEK293 COSMC/POMGnT1/POMT1/POMT2-/- cells and O-
glycosylated E-cadherin still bound to Con A (Figure 2.5B, lane 2, middle blot). 
However, in HEK293 COSMC/POMGnT1/TMTC1/2/3/4-/- cells, O-glycosylated E-
cadherin was not recovered by Con A after N-linked glycan removal suggesting a 
significant loss of both N- and O-linked glycans (Figure 2.5B, lane 2, bottom blot). This 
result was similarly observed in quadruple TMTCs knockout cells transfected with S-
tagged TMTC1, 2 or 4 (Figure 2.5B, lanes 4, 6 and 10, bottom blot). However, cells 




cadherin (Figure 2.5B, lane 8, bottom blot). The recovery of O-glycosylated E-cadherin 
by TMTC3 expression was repeated and quantified to confirm that TMTC3 contributed 
to the O-linked glycosylation of E-cadherin (Figure 2.5C).  
To determine whether TMTC3 mediated O-linked glycosylation of E-cadherin 
included O-mannosylation, a combinatorial endoglycosidase assay was performed. S-
tagged TMTC3 was transfected into HEK293 COSMC/POMGnT1/TMTC1/2/3/4-/- cells 
and the lysate was subsequently treated with PNGaseF or both PNGaseF and 1-2,3,6 
mannosidase prior to affinity purification with Con A, as the mannosidase would 
specifically remove mannose residues. O-glycosylated E-cadherin was recovered from 
cells complemented with TMTC3 after PNGaseF treatment; however, the amount bound 
to Con A upon subsequent 1-2,3,6 mannosidase treatment was reduced by ~45%, 
indicating that TMTC3 contributes to O-mannosylation of E-cadherin (Figure 2.5D 
insert, compare lanes 3 to 2).  
2.3.5 TMTC3 enhances cellular adherence and binding to E-cadherin. 
Studies on protein O-mannosylation in yeast have revealed that O-glycans are 
important for protein stability, trafficking, localization, function and stress response 
(Petkova et al., 2012; Xu and Ng, 2015; Yang et al., 2009). To understand the effect of 
TMTC3 on E-cadherin, the expression, stability and trafficking of E-cadherin was 
assessed in TMTC1-4 knockout cells. Briefly, HEK293 COSMC/POMGnT1-/-, 
COSMC/POMGnT1/POMT1/2-/- and COSMC/POMGnT1/TMTC1/2/3/4-/- cells were 
lysed and subjected to lectin affinity purification with Con A prior to samples being 
analyzed via SDS-PAGE and immunoblotted with E-cadherin antisera. There was no 




of E-cadherin was also assessed by a cycloheximide chase assay and a significant 
difference was not observed (Figure 2.6B). Cell surface localization of several cadherins, 
including E-cadherin, was monitored using confocal immunofluorescence microscopy. 
HEK293 COSMC/POMGnT1-/-, COSMC/POMGnT1/POMT1/2-/- and 
COSMC/POMGnT1/TMTC1/2/3/4-/- cells were fixed and stained for pan-cadherin 
(Figure 2.7A). In all three cell lines, cadherins localized to the cell surface. Interestingly, 
a morphology defect was observed in cells lacking TMTC1-4. While cell surface staining 
in HEK293 COSMC/POMGnT1-/- and COSMC/POMGnT1/POMT1/2-/- cells appeared 
round and evenly distributed, cadherin staining in HEK293 
COSMC/POMGnT1/TMTC1/2/3/4-/- cells showed greater irregularity.  
Cell-cell adhesion interactions are essential for embryogenesis, tissue 
morphogenesis and renewal (Halbleib and Nelson, 2006). Adherins junctions are the sites 
of cell-cell contact where adhesion is mediated by cell-surface receptors of the cadherin 
family (Meng and Takeichi, 2009). E-cadherin plays a critical role in cell-cell adhesion 
and development and O-mannosylation has been shown to be important for its role in 
forming adherens junctions (Lommel et al., 2013). To determine the effect of TMTCs on 
E-cadherin mediated cellular adherence, general cellular adherence was evaluated. 
HEK293 COSMC/POMGnT1-/-, COSMC/POMGnT1/POMT1/2-/- and 
COSMC/POMGnT1/TMTC1/2/3/4-/- cells were re-suspended in growth media and 
subsequently plated and allowed to adhere for 30 min. After 30 min, the floating cells 
were collected for each cell type and adhered cells were trypsinized and collected. Each 
fraction was quantified and the percent of floating cells over the total was calculated. 




similar levels of adherence with average floating cell percentages at ~23% (Figure 2.7B). 
Contrastingly, HEK293 COSMC/POMGnT1/TMTC1/2/3/4-/- cells demonstrated reduced 
cellular adherence as the percentage of floating cells observed was ~33% (Figure 2.7B). 
To determine if any one of the TMTCs individually contributed to cellular adherence, 
TMTC1, 2, 3 and 4 cDNA was transfected into HEK293 
COSMC/POMGnT1/TMTC1/2/3/4-/- cells. The adherence assay described above was 
performed and the percentage of adhered cells as compared to mock was calculated. 
Upon establishing a baseline using the mock treated cells, TMTC3 transfected cells were 
able to recover adherence the most with an observed increase over mock of ~8% (Figure 
2.7C).  
Cadherins are cell-surface membrane glycoproteins that contain multiple repeats 
of extracellular cadherin (EC) domains and they mediate cell-cell adhesion by trans 
homodimerization between apposed cells (Brasch et al., 2012; Cavallaro and Christofori, 
2004; Yagi, 2008). E-cadherin mediated cell-cell adhesion was assessed in HEK293 
COSMC/POMGnT1-/-, COSMC/POMGnT1/POMT1/2-/- and 
COSMC/POMGnT1/TMTC1/2/3/4-/- cells to determine if genetic manipulation of the 
glycosyltransferases affected its adhesion function. E-cadherin substrate was incubated 
overnight to allow for attachment to the plate surface. HEK293 COSMC/POMGnT1-/-, 
COSMC/POMGnT1/POMT1/2-/- and COSMC/POMGnT1/TMTC1/2/3/4-/- cells were 
then resuspended and ~60,000 cells were seeded on the substrate. Cells were allowed to 
adhere for 1 hr prior to discarding unadhered cells. Adhered cells were then fixed with 
paraformaldehyde before permeabilization with triton X-100, and nuclei were stained 




and the number of nuclei quantified. COSMC/POMGnT1/TMTC1/2/3/4-/- cells showed 
markedly reduced binding to the extracellular region of E-cadherin compared to 
COSMC/POMGnT1-/- and COSMC/POMGnT1/POMT1/2-/- cells (Figure 2.7D and E). 
The same assay was performed on COSMC/POMGnT1/TMTC1/2/3/4-/- cells expressing 
TMTC3 and E-cadherin mediated adherence was recovered. These results, combined 
with the results from the carbohydrate binding assay (Figure 2.5B-D), suggest that 
TMTC3 affects E-cadherin mediated adherence through O-mannosylation of the 
glycoprotein. 
2.3.6 TMTC3 disease variants exhibit reduced stability. 
Cell-cell adhesion interactions are essential for embryogenesis, tissue 
morphogenesis and renewal, all key processes of development (Halbleib and Nelson, 
2006). Cobblestone lissencephaly is a severe brain malformation characterized by 
irregular borders, dysplasia, hypoplasia and dysmyelination, which are due to 
overmigration of neurons and glial cells beyond the external basement membrane. The 
cause of this over migration defect is impaired interactions between glial limitans and the 
extracellular matrix of the basement membrane (Barkovich et al., 2012; Siegenthaler and 
Pleasure, 2011). Glycosylated cell surface binding receptors provide a physical link 
between the cytoskeleton of the glial cells and the basement membrane (Barresi and 
Campbell, 2006). Loss of glycosylation of these molecules contributes to functional 
defects during development by reducing binding to the extracellular matrix (Michele et 
al., 2002). Cobblestone lissencephaly has been associated with mutations in sixteen 
genes, and twelve of these genes are involved in O-linked glycosylation, including 




Recently, a study identified biallelic mutations in TMTC3 from Cobblestone 
lissencephaly patients exhibiting intellectual disability, hypotonia and delayed milestones 
(Jerber et al., 2016). Six families had a total of eight distinct mutations in affected 
individuals. Using predictive algorithms, the altered organization of seven of these 
mutants and a heterozygous PVNH-associated mutant (R71H) was analyzed (Figure 
2.8A). The point mutations do not appear to alter organization; however, the resulting 
residue mutations change the charge of the native residue, which may have some 
topological or functional effect on TMTC3 as some of these mutations are in close 
proximity to the putative active sites (Figure 2.8A, H67D, R71H and G384E). The frame 
shift mutations beginning at residue positions 488, 562 and 654 greatly change the 
number and organization of the predicted TPR motifs resulting in truncated forms of 
TMTC3. Additionally, these frameshift mutations could result in five to seven non-native 
amino acids being transcribed before the premature stop. The frameshift mutation at 
position 841 results in a shortened C-terminus and three putative non-native residues, and 
the early stop codon mutation at position 873 would result in a protein that is missing 41 
amino acids. 
TMTC3 disease variants were characterized for ER localization via glycosidase 
assay and immunofluorescence confocal microscopy. TMTC3 disease variant constructs, 
engineered to harbor any resulting non-native residues and C-terminal S-tags, were 
transfected into HEK293T cells prior to cell lysate and media fractions being affinity 
purified with S-protein agarose beads followed by glycosidase treatment. Shifts upon 
PNGaseF treatment (Figure 2.8B, lanes 3 and 9) were observed for all constructs 




similar increase in mobility was observed upon Endo H treatment indicating that the 
carbohydrates were high mannose glycoforms (Figure 2.8B, lanes 2 and 8). All TMTC3 
disease variants co-localized with calreticulin (CRT), while co-localization was not 
observed with the Golgi marker GM130 when immunofluorescence staining was 
performed in transfected COS7 cells (Figure 2.9). Therefore, the glycosylation profiles 
and the cellular distribution are consistent with TMTC3 disease variants residing in the 
ER like WT TMTC3.  
The only exception to ER localization studies was the frameshift mutation 
R488Efs. This mutant did not express in COS7 cells so cellular localization via 
immunofluorescence was unable to be determined. In order to assess expression of 
R488Efs S-tag, MG132, a proteasome inhibitor, was added to the media of cultured cells 
transfected with the S-tagged mutant construct. The immunoblot revealed that R488Efs 
was stabilized by proteasome inhibition suggesting that once translated, it is quickly 
degraded (Figure 2.10C, compare lane 3 to 4). Additionally, a glycosylation profile was 
obtained using proteasome inhibition (Figure 2.8B, top right panel). A shift upon EndoH 
and PNGaseF treatment was not observed, therefore this mutant may not be glycosylated. 
This could be explained by the predictive organizational outcome of this variant as the 
frameshift results in a severe truncation of the protein, including most of the predicted N-
linked glycosylation sites (Figure 2.8A). 
The rapid degradation of the R488Efs variant suggested that instability of TMTC3 
could lead to disease, therefore the stability of the remaining disease variants was 
analyzed. HEK293T cells were transfected with the S-tagged TMTC3 mutant constructs 




indicated time points, lysed and subjected to S-protein affinity purification (Figure 
2.10A). WT TMTC3 has a half-life of ~12 hr (Figure 2.10B, black line). Several of the 
mutants show similar or slightly extended half-lives; however, F562Lfs and G384E 
mutations lead to significantly reduced half-lives of ~8 and 2 hr, respectively (Figure 
2.10B, light blue and purple lines). This increased instability could explain a disease 
phenotype. Three of the disease variants are rapidly recognized as non-native and 
degraded. Further biochemical investigation is necessary to better understand the effects 
of such mutations. 
2.3.7 TMTC3 and TMTC4 knockdown delays gastrulation in Xenopus laevis. 
Tissue morphogenesis during development is dependent upon the cadherin family 
of cell-cell adhesion molecules, which includes classical cadherins, protocadherins and 
atypical cadherins (Halbleib and Nelson, 2006). During vertebrate morphogenesis, the 
various cadherin family members are differentially expressed in a variety of tissues 
(Nandadasa et al., 2009). E-cadherin has been shown to play a central role in cell-cell 
adhesion during embryo development before implantation. If O-mannosylation is 
prevented either genetically or biochemically, embryo development is arrested (Lommel 
et al., 2013). Staining for E-cadherin during mouse embryonic development showed that 
it is retained basolaterally, however, it was reduced at sites that also showed reduced 
adherence. 
Analysis of the TMTCs protein sequence conservation among commonly studied 
species revealed strong similarity to the TMTC paralogues in Xenopus laevis, therefore 
the potential phenotypic effects of TMTC knockdown in developing Xenopus embryos 




maternally persisting during early cell division and gastrulation. During gastrulation, E-
cadherin is expressed in the ectoderm. At the end of gastrulation, the ectoderm becomes 
segregated into the dorsal neural ectoderm, which then activates expression of N-cadherin 
and turns off E-cadherin. The non-neural ectoderm retains E-cadherin expression 
becoming the epidermis (Nandadasa et al., 2009). A global mRNA expression study 
conducted in developing Xenopus embryos showed that TMTC3 and TMTC4 mRNA are 
maternally expressed and that TMTC3 is strongly expressed during the mid-blastula 
transition (MBT) and remains abundant throughout gastrulation (Figure 2.11B) (Session 
et al., 2016). As both E-cadherin and TMTC3 and TMTC4 mRNA begin to increase in 
expression prior to gastrulation phase, the effect of TMTC knockdown was observed 
during gastrulation. 
Morpholino sequences (Genetools LLC) were designed to match the ATG region 
of Xenopus laevis TMTC1 to 4 to block protein translation of both allo allele (L and S). 
Individual morpholinos were microinjected into embryos at the 1-cell stage to ensure that 
every cell contained morpholino upon subsequent divisions. The injected embryos were 
allowed to develop as normal and gastrulation was observed via time-lapse video 
microscopy using an inverted light microscope. The diameter of the blastopore was 
measured during gastrulation (stage 10-12) for all injected embryos as well as non-
injected controls. Those injected with the TMTC1, 2, 3 or 4 morpholino showed a 
significant delay in gastrulation as exhibited by a larger blastopore diameter than non-
injected controls at the same time point (Figure 2.12A and B). The most significant effect 
was observed for TMTC3 and TMTC4 morpholino injected embryos. With TMTC3 




specificity of this delay in gastrulation, human WT TMTC3 mRNA was subsequently 
injected after the TMTC3 morpholino in 1-cell stage embryos and gastrulation was 
observed as previously described (Figure 2.12A and B). Human WT TMTC3 was able to 
completely rescue the delay in gastrulation caused by knocking down Xenopus TMTC3, 
suggesting that the developmental defect is specific to TMTC3 and that the human and 
Xenopus proteins share similar functions.  
The O-mannosyltransferases POMT1/2 and Pmt1-7 contain diacidic motifs 
positioned near the membrane in the lumen of the ER, which are hypothesized to serve as 
the active site for the transferase activity (Figure 2.4B) (Bai et al., 2019; Lommel et al., 
2011). TMTC3 has two N-terminal diacidic motifs that are proposed to be luminally 
orientated, Asp31Asp32 (DD) and Glu73Glu74 (EE) (Figure 2.4C). To determine 
whether a putative active site could be assigned to TMTC3, the diacidic motifs were 
mutated to di-Ala motifs. The TMTC3 DD>AA and EE>AA constructs were injected at 
the 1-cell stage with TMTC3 morpholino. While injected embryos were observed for 
gastrulation, a number of embryos were also collected to assess construct expression. 
Briefly, embryos were homogenized in lysis buffer prior to total protein precipitation 
with trichloroacetic acid and analysis by SDS-PAGE and immunoblotting for S-tag 
epitope (Figure 2.11C). The analysis showed that all constructs, human WT TMTC3, 
DD>AA and EE>AA were similarly expressed. While the WT TMTC3 was able to 
rescue the gastrulation defect, neither the DD>AA nor EE>AA construct could (Figure 
2.12A and B). Given that a point mutation in TMTC3 (G384E) resulted in significantly 




two negatively charged residues within the first luminal loop of TMTC3 to neutral Ala 
could affect function of TMTC3.  
Mutations in TMTC3 have been identified in patients with diseases resulting from 
defects in cell migration. Since the process of gastrulation in metazoans is dependent 
upon a series of complex and coordinated cell movements, TMTC3 disease variants were 
assessed in the previously described Xenopus gastrulation assay (DeSimone et al., 2007; 
Winklbauer, 2012). One-cell stage embryos injected with TMTC3 morpholino were 
subsequently injected with human TMTC3 mRNA harboring three of the point mutations 
found in patients, H67D, R71H and G384E (Figure 2.8A). The embryos were allowed to 
develop to gastrulation prior to being assessed as previously described. TMTC3 
morpholino injected embryos display an average increased blastopore diameter of ~880 
m compared to non-injected or WT TMTC3 rescue controls, ~530 and ~600 m, 
respectively (Figure 2.12A and B). TMTC3 disease mutants H67D, R71H and G384E 
possessed increased blastopore diameters of ~1100, ~1000 and ~930 m, respectively. 
This data shows that while WT TMTC3 rescues the gastrulation defect, the disease 
variants resulting in point mutations in TMTC3 increased developmental delays 
suggesting that they may act as dominant negative mutants.  
2.4 Discussion 
Our study demonstrates that TMTC3 O-mannosylates E-cadherin and this 
modification is important for E-cadherin mediated cell-cell adhesion. TMTC3 is an 
integral ER membrane protein, likely adopting a polytopic structure, with its putative 
TPR region residing within the ER lumen. The knock down of Tmtc3 in Xenopus laevis 




adhesion and migration (Winklbauer, 2012). Although the TMTCs all share similar 
protein domain architecture and the TMTC mRNA profiles is comparable to previously 
known O-mannosyltransferases, POMT1 and 2, TMTC3 appears to play a critical role in 
cell adhesion. This study provides insight into cell migration diseases caused by 
mutations in TMTC3. 
TMTC3 shares 24-28% identity and 38-43% similarity in amino acid sequence 
with the other members of the TMTC protein family, suggestive of a common 
evolutionary origin (Sievers et al., 2014). TMTC3 and TMTC4 are present in the 
chordata phylum and recent analysis shows that they are even conserved in protists 
(Larsen et al., 2019). Like TMTC1 and TMTC2, TMTC3 and TMTC4 are divided into 
two regions that appear to create distinct domains, an N-terminal hydrophobic region and 
a C-terminal domain consisting of large TPR clusters (Sunryd et al., 2014). G predicts 
that TMTC3 and TMTC4 have ten and twelve potential transmembrane domains, 
respectively (Figure 2.1A). Alkaline extraction of total membrane preparations 
demonstrated that TMTC3 and TMTC4 are integral membrane proteins and trypsin 
digestion of these preparations produced partially protected C-terminal fragments of both 
TMTC3 and TMTC4 that correspond to the entire predicted C-terminal TPR region, as 
well as a number of the hydrophobic segments. Therefore, TMTC3 and TMTC4 appear 
to be polytopic membrane proteins with their hydrophobic N-termini providing long 
stretches of multiple hydrophobic segments and exposed cytoplasmic loops. 
Protein O-mannosylation involves the transfer of a mannose from an activated 
dolichol monophosphate mannose to the hydroxyl group on a Ser or Thr. The O-




Glu) that resides near the membrane in luminal loop 1 of the polytopic proteins (Figure 
2.4B) (Bai et al., 2019; Lommel et al., 2011). TMTC3 possesses two diacidic motifs in 
the first predicted luminal loop (Asp31Asp32 (DD) and Glu73Glu74 (EE)) (Figure 2.4C). 
These diacidic residues were mutated to Ala and the stability of TMTC3 was monitored 
(Figure 2.13B, lower panel). While TMTC3EE>AA was expressed at similar levels to WT 
TMTC3, TMTC3DD>AA was not visualized after transfection. To determine if 
TMTC3DD>AA was unstable, a cycloheximide chase was carried out for WT TMTC3, 
TMTC3DD>AA, and TMTC3EE>AA (Figure 2.13C). TMTC3DD>AA was turned over rapidly 
when compared to WT TMTC3 and TMTC3EE>AA indicating that TMTC3DD>AA was 
unstable. Even though the instability of TMTC3DD>AA prohibited us from comparing its 
ability to rescue the O-mannosylation of E-cadherin in 
COSMC/POMGnT1/TMTC1/2/3/4-/- HEK293 cells to WT TMTC3 and TMTC3EE>AA, 
we were able to show that TMTC3EE>AA rescues O-glycosylation of E-cadherin as E-
cadherin still binds Con A in TMTC3EE>AA transfected cells (Figure 2.13B, upper panel 
lane 8). This potentially links the TMTC3 Asp31Asp32 (DD) diacidic motif to its 
activity. In Xenopus, neither the TMTC3EE>AA nor TMTC3DD>AA construct was able to 
rescue the delay in gastrulation caused by the TMTC3 morpholino (Figure 2.12A and B). 
These results indicated that the diacidic residues in loop 1 were important for protein 
stability and possibly the transferase activity. 
The glycosylation profiles combined with the trypsin protection of the C-terminal 
domains, placed the TPRs within the ER lumen for both TMTC3 and TMTC4. This is 
similar to the TPR regions of TMTC1 and TMTC2 (Sunryd et al., 2014). TMTC3 and 




(Karpenahalli et al., 2007). TPR domains are found in proteins across species and 
organelles and participate in a number of activities including protein translocation, 
folding, and post-translational modification (Graham et al., 2019). Furthermore, TPR-
containing proteins comprise the largest functional family within the cellular 
proteostasis/chaperome network (Brehme et al., 2014). TPRPred predicted that the eleven 
TPR motifs of TMTC3 are organized into clusters of three and eight, while TMTC4 has 
eight sequential TPRs. The differences in the organization of the TPR domains for 
TMTC3 and TMTC4 could have implications for their functions. 
Extensive bioinformatic analysis shows that long stretches of consecutive TPR 
domains (observed up to sixteen) tend to be more promiscuous in their selectivity 
(Magliery and Regan, 2005). Given that TMTC3 and TMTC4 both possess a stretch of 
eight consecutive motifs, this suggests that they may bind a number of substrates. This is 
most similar to the well-studied TPR-containing cytoplasmic O-GlcNAc transferase 
(OGT), which contains a stretch of 12.5 TPRs. The structure of OGT revealed that the 
TPRs form a super helix with conserved Asn along the concave surface that form a 
continuous ladder (Figure 1.1C). The Asn in OGT that are particularly well-conserved are 
those at positions 6 and 9 in the TPR consensus and thought to contribute to inter-repeat 
interactions (Jínek et al., 2004). Seven of the eleven TPRs in TMTC3, as predicted by 
TPRPred, have Asn at position six and seven out of eight of the TPRs in TMTC4 have 
Asn at position six in addition to two of the eight having Asn at position nine. The 
number of conserved Asn at positions six and nine of the predicted TPRs in TMTC3 and 
TMTC4 suggests that they may form super helical structures and use the Asn to nucleate 




ARM-repeat proteins importin- and -catenin, which contribute to the binding of the 
target peptide (Conti et al., 1998; Huber and Weis, 2001). -catenin was shown to 
interact with E-cadherin through conserved Asn on its ARM-repeat domains (Huber and 
Weis, 2001). -catenin has twelve ARM-repeat domains and five of the domains contain 
an Asn at position 13 and are responsible for recognizing the backbone of extended 
peptides. Furthermore, alignment of murine cadherin family sequences (M-cadherin, OB-
cadherin, desmocollin 1a and desmoglein 1) to E-cadherin show that many of the 
observed E-cadherin/-catenin interactions are likely to be conserved among other 
cadherin family members. TMTC3 contains seven Asn at a conserved position on its TPR 
motifs, which could be used to interact with the well conserved family of cadherins in 
order to recruit the substrates for O-mannosylation near the ER membrane (Figure 4.1B). 
Analysis of TPR-containing protein structures and their ligands revealed that 
smaller clusters of three and four TPRs corresponds to co-chaperone function (Brehme et 
al., 2014; Graham et al., 2019). Like one of the most well-studied TPR structures in the 
protein HOP, the N-terminal cluster of three TPRs in TMTC3 may bind and recruit 
chaperones for protein homeostasis, analogous to the MIR domains in the POMT/Pmts 
(Fujimori et al., 2017; Scheufler et al., 2000). MIR domains are observed in six non-
redundant proteins, all of which target to the ER (Letunic and Bork, 2018; Nielsen, 
2017). Stromal cell-derived factor 2 (SDF2) is a small protein of 211 amino acids 
comprised primarily of three MIR domains. While not much is known about MIR domain 
function for SDF2 and its isoform, SDF2L1, their MIR domains have been found to 
regulate the chaperone cycle of BiP (Fujimori et al., 2017). Both proteins form a stable 




ER cargo by binding non-native proteins and promoting the BiP-substrate interaction 
cycle. We hypothesize that the three TPR motif cluster of TMTC3 may form a similar 
complex with chaperones for the delivery of unfolded substrate in order to expose 
putative sites for O-mannosylation. 
Thirty-seven members of the cadherin superfamily of cell membrane receptors 
were identified as major carriers of O-mannose glycans (Vester-Christensen et al., 2013). 
Cell-surface receptors of the cadherin family mediate cell-cell adhesion at sites of cell-
cell contact, which is crucial for cells to function in an integrated manner (Lodish et al., 
2000; Meng and Takeichi, 2009). In our study, cells lacking TMTC1-4 stained for 
cadherins display cell-cell attachment irregularity appearing less round and consistent in 
shape (Figure 2.7A). In combination with the data demonstrating that TMTC3 is involved 
in the O-mannylation of E-cadherin, this suggests that TMTC3 plays a role in cellular 
adherence through the O-mannosylation of E-cadherin. 
Cadherins contain multiple repeats of extracellular cadherin (EC) domains and 
they mediate cell-cell adhesion by trans homodimerization between the most distal EC1 
and EC1-2 domains on apposed cells (Brasch et al., 2012; Cavallaro and Christofori, 
2004; Yagi, 2008). The other EC domains play a critical role in presenting the EC1 and 2 
domains so that they may form these homodimers. The O-mannose modified sites 
identified are confined to the EC2-5 domains of both classic type 1 and 2 cadherins and 
these sites also appear to be evolutionarily conserved. E-cadherin, a type I classical 
cadherin, holds most epithelial sheets together and is highly abundant at the sites of cell-
cell contact along lateral surfaces (Lodish et al., 2000). We found that 




extracellular region of E-cadherin than HEK293 COSMC/POMGnT1-/- and 
COSMC/POMGnT1/POMT1/2-/- cells suggesting that genetic manipulation of the 
TMTCs affects E-cadherin’s ability to transhomodimerize (Figure 2.7D and E). 
Complementation with TMTC3 in COSMC/POMGnT1/TMTC1/2/3/4-/- HEK293 cells 
increased E-cadherin mediated cell-cell adhesion, therefore demonstrating that TMTC3 
O-mannosylation of E-cadherin plays a crucial role in its ability to homodimerize (Figure 
2.7D and E, and Figure 2.5). Given that E-cadherin is also crucial during embryogenesis, 
the effects we observe upon knockdown of Tmtc3 and subsequent rescue of the 
gastrulation delay with human TMTC3 WT, could be attributed to the role TMTC3 plays 
in E-cadherin mediated cell-cell adhesion and O-mannosylation (Figure 2.12A and B) 
(Halbleib and Nelson, 2006). 
Mutations in TMTC3 were identified in patients with Cobblestone lissencephaly 
and periventricular nodular heterotopia (PVNH), common brain malformations caused by 
defects in neuronal migration (Farhan et al., 2017; Jerber et al., 2016). More specifically, 
three of the mutations (R488Efs, F562Lfs and G384E variants) identified in Cobblestone 
lissencephaly patients that possess a significant number of clinically observed 
neurological defects were found to be unstable in our protein degradation assay (Figure 
2.10) (Jerber et al., 2016). The rapid degradation of these variants could explain the 
development delays observed in patients due to lack of TMTC3. Our Xenopus 
developmental studies revealed that two of the mutants (H67D and R71H) lead to a 
developmental delay even though they were more stable in cells. Our characterization of 
the disease variants of TMTC3 provides a link between a previously uncharacterized 




TMTC1-4 are not only implicated in the O-mannosylation of cadherins but were 
also found to be involved in the O-mannosylation of several ER/Golgi resident proteins, 
including ERp57, ERdj4 and FKBP10 (Larsen et al., 2017a). Each of these are important 
chaperones for protein folding of the secretory pathway aiding in disulfide bond 
formation, BiP activation and proline cis trans isomerization. O-mannosylation of both 
trafficked and resident secretory pathway proteins could contribute to their quality 
control either through increasing favorable folding or enhancing degradation of specific 
substrates upon misfolding. While previous studies show that O-mannosylation is an 
important structural modification, recent studies show that it may also play a role in ER 
quality control (ERQC) (Xu and Ng, 2015). If certain mutants are stabilized, they could 
cause dysregulation of protein homeostasis due to an excess of O-mannose modification 
of particular ER resident chaperones. 
In conclusion, we demonstrate that TMTC3 is crucial for O-glycosylation of E-
cadherin and cell-cell adhesion and embryonic development. Evidence shows that 
although the TMTCs share architectural similarity, they perform distinct functions and 
help to regulate cellular homeostasis by participating in essential processes, post-
translational modification and calcium regulation. TMTC3 directed O-mannosylation is 
biologically important and further studies are of interest to better understand TMTC3’s 
function within the cell and how mutations in this gene cause disease. 
2.5 Materials and Experimental Procedures 
2.5.1 Plasmids and reagents 
Dulbecco's modified Eagle's medium (DMEM), DMEM GlutaMax, fetal bovine 




Scientific. Easy-Tag [35S]-Cys/Met was purchased from PerkinElmer Life Sciences. S-
protein-agarose beads and S-tag antibody were purchased from EMD Millipore. Endo H, 
PNGase F, Protoscript II first strand cDNA synthesis kit and all cloning reagents were 
purchased from New England Biolabs. FastStart SYBR Green qPCR mix was purchased 
from Roche Diagnostics, and all primers were acquired from IDT DNA. IRDye® 800CW 
Goat anti-Mouse IgG and IRDye® 680RD Goat anti-Rabbit IgG were purchased from Li-
COR Biosciences. Protein A sepharose CL-4B was purchased from GE Healthcare. 
Antibodies directed toward the following antigens were also purchased: calnexin (Enzo 
Life Sciences); calreticulin (ThermoFisher Scientific); E-cadherin (GeneTex); pan-
cadherin (Sigma); ERp57 (gift from Dr. Taku Tamura, Akita University, Japan), GM130 
(BD Biosciences) and KDEL (Enzo Life Sciences). TMTC3 and TMTC4 cDNA was 
created by isolating RNA (HEK293T cells) and cloned into pcDNA3.1 A−, a plasmid 
harboring a C-terminal S-tag, using standard molecular biology techniques. All other 
chemicals were obtained from Sigma.  
2.5.2 Cell lines/Tissue Culture 
HEK293T, 293A or COS7 cells were grown in DMEM supplemented with 10% 
fetal bovine serum, 100 U/mL penicillin and 100 mg/ml streptomycin. HEK293 cell lines 
(COSMC/POMGNT1-/-, COSMC/POMGNT1/POMT1/2-/-, and 
COSMC/POMGNT1/TMTC1/2/3/4-/-) were generously contributed by Dr. Henrik 
Clausen (University of Copenhagen) and grown in DMEM GlutaMax supplemented with 
10% fetal bovine serum.  




The primary amino acid sequences of TMTC3 and TMTC4 were analyzed by 
UniProtKB and TPRpred to identify the number and position of putative TPR domains 
(Xu and Ng, 2015)(Karpenahalli et al., 2007, 2019). Hydrophobic domains were 
identified by the ΔG software, which predicts transmembrane domains (Hessa et al., 
2007). Putative N-linked glycosylation sites were identified by NetNGlyc (Gupta, 2002).  
2.5.4 Affinity Purification and glycosylation assay 
Transfected cells were lysed in MNT buffer (0.5% Triton X-100, 20 mM MES, 
100 mM NaCl, 30 mM Tris-HCl [pH 7.5]). All steps were conducted at 4 C. The post-
nuclear supernatant (PNS) was isolated by centrifugation followed by pre-clearing with 
un-conjugated agarose beads for 1 hr. Cleared supernatant was incubated with S-protein 
agarose beads overnight and subsequently washed twice with wash buffer (0.05% Triton-
X-100, 0.1% SDS, 300 mM NaCl, 100 mM Tris-HCl [pH 8.6]). After the final wash, 
glycosylation assays were performed by adding appropriate buffers and either mock, 
Endo H or PNGase F enzymes according to the manufacturer’s protocol. Finally, 
reducing sample buffer was added to all samples and they were analyzed by SDS-PAGE.  
2.5.5 Confocal Microscopy 
Cells were fixed with 3.7% paraformaldehyde in phosphate buffered saline (PBS) 
for 15 min followed by permeabilization with 0.1% triton X-100 for 15 min at 25 C. 
Slides were stained with the indicated primary antibodies followed by staining with 
appropriate Alexa Fluor 488 or 594 secondary antibodies in immunostaining buffer (10% 
fetal bovine serum in 1X PBS). Slides were rinsed and mounted onto cover slips with 
VectaShield (Vector Laboratories). Images were obtained with a Fluoview 1000 MPE, 




Hamamatsu C8484-05G camera. All images were acquired with a Plan Apo N 60x 
1.42NA lens and processed by using the FV10-ASW and Adobe Photoshop software. For 
pan-cadherin staining, 24-well glass bottomed plates were prepared with 0.1% gelatin in 
PBS for 1 hr at 37 C prior to coating each well with 10 µg/mL fibronectin (Sigma) 
overnight at 4 C. Cells were allowed to adhere in the wells for 2 hr at 37 C and 
subsequently fixed in methanol for 10 min at -20 C. Cells were stained with the 
indicated primary antibodies followed by staining with appropriate Alexa Fluor 488 or 
594 secondary antibodies in 1X PBS containing 0.1% Tween, 2% bovine serum albumin 
(Fisher) and 0.02% sodium azide. Cells were rinsed and then incubated with Hoescht 
(Abcam) for 1 hr at 25 C. Images were obtained with a A1R: Nikon A1 resonant 
scanning confocal with TIRF module microscope equipped with an Andor Xyla camera. 
All images were acquired with a Plan Apo IR 60x 1.27WI lens and processed by using 
the Nikon Elements and Adobe Photoshop software.  
2.5.6 Alkaline extraction 
Alkaline extraction was performed as previously described (Sunryd et al., 2014). 
Briefly, radiolabeled cells were resuspended in ice-cold homogenization buffer (20 mM 
HEPES, 5 mM KCl, 120 mM NaCl, 1 mM EDTA, and 0.3 M sucrose [pH 7.5]) and 
passed through a 25-gauge needle 20-times. All subsequent steps were conducted at 4 C. 
The homogenate was centrifuged at 1,000 g for 10 min to pellet the nuclear fraction. The 
remaining PNS was centrifuged at 45,000 rpm in Beckman rotor (TLA 120.2) for 10 min 
to separate the cytosol (supernatant) from the cellular membranes (pellet). The cellular 




resuspended membranes was incubated with 0.1 M Na2CO3 (pH 11.5) for 30 min on ice. 
The alkaline extracted portion was centrifuged at 65,000 rpm for 20 min through a 
sucrose cushion (50 mM triethanolamine, 0.3 M sucrose [pH 7.5]) to separate soluble 
proteins from membrane proteins in the supernatant and pellet, respectively. The pH was 
adjusted in the alkaline extracted sample with 1 M Tris-HCl (pH 7.5). An excess of MNT 
was added to all fractions, and immunoprecipitation or affinity precipitation was 
performed with protein-A sepharose and appropriate antisera or with S-protein agarose, 
respectively.  
2.5.7 Trypsin protection 
Transfected cells were resuspended in cold homogenization buffer (10 mM 
HEPES [pH 7.4], 10 mM KCl, 1.5 mM MgCl, 5 mM sodium EDTA, 5 mM sodium 
EGTA and 0.25 M sucrose) and passed through a 25-gauge needle 20-times.  All 
subsequent steps were conducted at 4 C. The homogenate was centrifuged at 1,000g for 
10 min to pellet the nuclear fraction. The remaining PNS was centrifuged at 45,000 rpm 
in Beckman rotor (TLA 120.2) for 10 min to separate the cytosol (supernatant) from the 
cellular membranes (microsomes). The microsomes were resuspended in homogenization 
buffer containing 0.1 M NaCl and 10 µg trypsin and/or triton X-100 was added to a final 
concentration of 0.1%. After incubation at 27 C for 15 min, the reaction was quenched 
with 100 µg soybean trypsin inhibitor. Reducing sample buffer was added and analyzed 
via SDS-PAGE.  
2.5.8 Immunoblotting, endoglycosidase and affinity purification 
Non-transfected and transfected cells were lysed in MNT and the post-nuclear 




determination using 595 nm Protein Assay Dye Reagent (Bio-Rad). All subsequent steps 
were conducted at 4 C. Equal amounts of total protein were split into three fractions. 
Preclearing was performed on one of the fractions with control agarose beads for 1 hr 
prior to affinity purification with S-protein agarose beads overnight. The remaining two 
fractions were subjected to a glycosylation assay by adding appropriate buffers and either 
mock or PNGase F enzyme according to the manufacturer’s protocol. Following 
endoglycosidase treatment, affinity purification for glycoproteins using Con A (Sigma) 
was performed overnight. Beads were washed twice in wash buffer. Finally, reducing 
sample buffer was added to all samples and they were analyzed by SDS-PAGE. Proteins 
were transferred to a polyvinylidene difluoride membrane and immunoblotted with the 
appropriate antisera. Blots were developed and TIFF files were acquired using a LI-COR 
Odyssey CLx Imager. Densitometric quantification of western blots was performed using 
ImageJ software (Fiji). The amount of E-cadherin bound to Con A was calculated by 
dividing the amount of E-cadherin in the PNGaseF treated transfected cells with the 
amount of E-cadherin in the PNGaseF treated non-transfected cells (mock). The amount 
of E-cadherin in non-transfected cells was set to 100%. Error bars represent the standard 
deviation for three independent experiments. TMTC3 S-tag transfected samples were also 
subjected to a glycosylation and carbohydrate binding assay that included both PNGaseF 
and 1-2,3,6 mannosidase treatment. Briefly, transfected cells were lysed as described 
above and split into three fractions. Glycosylation assays were performed by adding 
appropriate buffers and either mock or PNGase F enzymes according to the 
manufacturer’s protocol and subsequent treatment with 1-2,3,6 mannosidase enzyme 




amount of E-cadherin bound to Con A was calculated by dividing the amount of E-
cadherin in PNGaseF/1-2,3,6-mannosidase treated samples by the amount of PNGaseF 
treated E-cadherin, which was set to 100%. Error bars represent the standard deviation 
for three independent experiments.  
2.5.9 qRT-PCR 
HEK293A cells were treated with regular growth media or dithiothreitol (2 mM) 
for 2 hr or tunicamycin (1 µg/mL), thapsigargin (3 µM), brefeldin A (2.5 µg/mL) and 
MG132 (2.5 µM) for 24 hr prior to RNA isolation with RNAeasy Mini Kit (Qiagen). One 
g of purified RNA was reverse transcribed into cDNA using the Protoscript II Reverse 
Transcriptase kit (New England Biolabs). Quantitative real time polymerase chain 
reactions (qRT-PCR) were performed in 20 µL reactions using the FastStart universal 
SYBR Green master (Rox) kit (Roche diagnostics Corp.) on an Mx3000P real-time PCR 
machine (Agilent Technologies Inc.) according to manufacturer’s instructions. Changes 
in mRNA levels were calculated using the change in cycle threshold value method with 
-actin as the reference gene (Pfaffl, 2001). Statistical analysis of the data was calculated 
using GraphPad Prism 5.0 (GraphPad software) and significance between treatment 
groups was determined using unpaired T-tests.  
 The following primers were used: -actin (5’ GCACTCTTCCAGCCTTCC 3’, 5’ 
TGTCCACGTCACACTTCATG 3’), TMTC1 (5’ GCTGTTTCTATTGGCCTTTCTC 
 3’, 5’ TGTCTCTTTCACCAGCATCG 3’), TMTC2 (5’ 
GATGTCTTTGTCTTTCACAGGC 3’, 5’ TGTTTCCCATCCAGTATAACCG 3’) 
TMTC3 (5’ TTTTCCTAAGCCATCCCCTG’, 5’ ACAAAACCACAAAAGAGGCTG 




ATAACGAGAAATCCCAGGCC 3’), POMT1 (5’ GTGAACTACCTCCCGTTCTTC 
3’, 5’ CACAGGGAGCAGAAGGATTT 3’), POMT2 (5’ 
GGCACTGGCCTATCAACTATC 3’, 5’ CAACAGATTCAGCCACCAAAC 3’) and 
BiP (5’ CTGCCATGGTTCTCACTAAAATG 3’, 5’ TTAGGCCAGCAATAGTTCCAG 
3’).  
2.5.10 Cycloheximide chase analysis 
HEK293T cells were transfected with S-tagged WT TMTC3 or mutant TMTC3 
for 40 hr prior to incubation with 100 µg/mL of cycloheximide for indicated times. Cell 
lysates were prepared and the expression of S-tag TMTC3 was analyzed by Western 
blots. Briefly, transfected cells were lysed in MNT. Protein concentration of cell lysates 
was determined by using the 595 nm Protein Assay Dye Reagent (Bio-Rad). Western 
blots were carried out after 9% SDS-PAGE. After incubation with IRDye-conjugated 
secondary antibodies, the protein-antibody complexes were visualized by the LI-COR 
Odyssey CLx Imager and densitometric quantification of western blots was performed 
using ImageJ software (Fiji). The stability of TMTC3 was calculated by dividing the 
amount of TMTC3 WT or mutants in cyclohexmide treated samples (2-24 hr time points) 
by the amount of TMTC3 in untreated samples (0 time point), which was set to 100%. 
Error bars represent the standard error for three independent experiments.  
2.5.11 Cell Adhesion Assays 
Substrates included bovine fibronectin (Sigma), E-cadherin (R&D Systems), and 
BSA (Fisher). Falcon Probind 96-well plates were coated with 25 and 50 μg/ml substrates 
in PBS overnight at 4 °C, rinsed with PBS, and blocked with 10 mg/ml BSA in PBS for 2 




60,000 cells/well were seeded and the adhesion assay was performed for 1 hr at 37 °C in 
5% CO2 in a humidified atmosphere. Non-adherent cells were washed away with serum 
free media. Adherent cells were fixed for 20 min with 4% formaldehyde in PBS, rinsed 
with PBS, and permeabilized with 0.1% triton X-100 for 20 min prior to staining with 
Hoescht (Abcam). Excess stain was removed with PBS. Each assay point was derived 
from three independent experiments.  
2.5.12 Xenopus embryo handling and media 
Eggs were obtained from adult Xenopus laevis, fertilized, and cultured as 
described previously (Cousin et al., 2008). Embryos were staged according to 
(Nieuwkoop and Faber 1994). Briefly, after in vitro fertilization, the eggs were dejellied 
in 2% cysteine (pH ~8.3) and then cultured in 3% Ficoll in Modified Barth’s Solution 
(1X MBS) at 15 °C until they reached the desired stage for injection. Embryos were 
grown in 0.1X MBS at either 15 or 18º C. Time-lapse video microscopy was performed 
at 18º C. 
2.5.13 Microinjection experiments 
Morpholinos (GeneTools, LLC) for TMTC1, 2, 3 and 4 were designed to block 
translation of the respective proteins and contain a 3’-fluorescein modification by the 
manufacturer and injected (10 ng) at the one-cell stage. mRNAs of human TMTC3 WT 
and previously described mutants, cloned into pcDNA3.1 A− with a C-terminal S-tag, 
were transcribed using T7 polymerase following linearization of plasmids with EagI or 
DraIII. Transcripts were desalted on G-50 Nick columns (Pharmacia), extracted with 




at 260 nm and resuspended at 0.2 mg/ml in DEPC-treated H2O. Transcripts (0.4-1 ng 
total) were injected at the one-cell stage, following injection of the TMTC3 morpholino.  
2.5.14 Embryo and cell imaging 
Pictures of embryos were taken using the Zeiss Axiovert 200 M inverted 
microscope equipped with a Ludl xyz-stage control and a Hamamatsu Orca camera 
(Figure 2.12) or BZ-X Analyzer equipped with Nikon 10X CFI PlanFluor lens and 
BZX710 camera (Keyence). Images were taken using either the AxioVision software 
(Zeiss) or the BZ-X capture software (Figure 2.12) (BZ-X700 Analyzer). The diameter of 
the blastopore was measured using ImageJ software (Fiji) and quantified using GraphPad 
Prism 5.0 (GraphPad software). Statistical analysis between morpholino and TMTC3 
construct injected groups was performed using one-way ANOVA and *, **, *** indicates 
a P-value of less than 0.05, 0.01 and 0.001, respectively. Error bars represent standard 
deviation.  
2.5.15 Protein extraction and analysis 
Embryonic proteins were extracted from 10-20 frozen embryos using 1X MBS 
(Laskey et al., 1977) containing 1% triton X-100, protease inhibitor cocktail (Sigma), 2 
mM phenylmethylsulfonide fluoride (PMSF), and 1 mM EDTA on ice followed by 
16,000 g centrifugation for 30 min at 4 C. Supernatant was either directly added to an 
equal volume of 2X Laemmli buffer containing 2% -mercaptoethanol or precipitated 
with trichloroacetic acid (Sigma) and washed with acetone prior to resuspension in 2X 
Laemmli containing 2% of -mercaptoethanol. Western blots were performed using 






Figure 2.1. TMTC3 and TMTC4 are ER resident proteins. (A) The organization of 
TMTC3 and TMTC4 with signal sequences (black), hydrophobic domains (blue) and 
TPR domains (orange) as designated. Predicted endogenous N-linked glycosylation sites 
are indicated by small black, branched structures. (B) HEK293T cells were transfected 
with S-tagged TMTC3 or TMTC4 as indicated and were affinity purified from the cell 
lysate and media using S-protein agarose. Samples were then subjected to a glycosylation 
assay with either EndoH (lanes 2, 5, 8, 11, 14 and 17) or PNGaseF (lanes 3, 6, 9, 12, 15 
and 18) digestion as indicated. Reducing sample buffer was added and the samples were 
analyzed by a 6% (TMTC3 S-tag) and 8% (TMTC4 S-tag) SDS-PAGE. (C) Cellular 
localization of TMTC3 and TMTC4 was investigated by confocal microscopy. COS7 
cells were transfected with TMTC3 or TMTC4 cDNA. Fixed cells were stained with S-
tag, ERp57 (ER) or GM130 (Golgi) antisera. Nuclei were visualized by DAPI staining 






Figure 2.2. TMTC3 and TMTC4 are transmembrane proteins with their TPR domains 
facing the ER lumen. (A) HEK293T cells were transfected with S-tagged TMTC3 or 
TMTC4 as indicated and radiolabeled for 1 hr with [35S]-Cys/Met. Cells were 
homogenized and fractionated prior to alkaline extraction. The fractions collected were 
whole cell lysate (WCL), nucleus (N), cytosol (C), total membrane (TM), as well as 
supernatant (S) and pellet (P) fractions upon alkaline extraction of the TM. All samples 
were subjected to affinity purification with S-tag agarose or calnexin (CNX) and 
calreticulin (CRT) immunoprecipitation where indicated. Samples were analyzed via 
SDS-PAGE and detected via autoradiography. (B) TMTC3 S-tag and TMTC4 S-tag were 
expressed in HEK293T cells. Cells were homogenized and microsomes were isolated by 
ultracentrifugation then resuspended in homogenization buffer. Aliquots of the ER 
microsomes were incubated for 15 min at 27 ˚C with or without triton X-100 and trypsin 
where indicated. Samples were separated on 9% SDS-PAGE and immunoblotted for the 
S-tag epitope. (C) Putative trypsin protease cleavage areas (dashed line) on TMTC3 and 







Figure 2.3. Basal transcript abundance and fold induction of TMTC proteins by ER 
stress. (A) RNA from HEK293A cells, grown under normal conditions, was harvested. 
RNA was reverse transcribed to cDNA followed by qRT-PCR with appropriate primers. 
Basal mRNA abundance was assessed using β-actin as a reference. Error bars represent 
standard error from at least three independent experiments. (B) HEK293A cells were 
treated with regular growth media or with 2 mM DTT for 2 hr, 1 μg/mL tunicamycin, 3 
μM thapsigargin, 2.5 μg/mL brefeldin A or 2.5 μM MG132 for 24 hr prior to RNA 
purification. RNA was reverse transcribed to cDNA followed by qRT-PCR with 
appropriate primers, and changes in gene expression were calculated using β-actin as a 
reference. Statistical significance between treatment groups was determined using an 
unpaired T test. * and ** indicates a P-value of less than 0.05 and 0.01, respectively. 






Figure 2.4. TMTCs and POMTs share similar functional domain architecture. (A) The 
organization of E-cadherin with signal sequence (black), extracellular cadherin domains 
(light blue) and transmembrane domain (dark blue) as designated. N-linked glycosylation 
sites are indicated by small black, branched structures and O-mannosylation sites by 
green circles. (B) The organization of yeast Pmt1 and predicted organization of human 
POMT1 and 2 with signal sequences (black), hydrophobic domains (dark blue) and MIR 
domains (pink) as designated. Predicted endogenous N-linked glycosylation sites are 
indicated by small black, branched structures and putative diacidic motif active sites are 
indicated in dark blue (red for active site that has been identified in yPmts). (C) Predicted 
organization of human TMTC3 with signal sequence (black), hydrophobic domains (dark 
blue), TPR domains (orange) and predicted active site (diacidic DE and EE residues in 








Figure 2.5. TMTC3 rescues O-mannosylation of E-cadherin in HEK293 
COSMC/POMGnT1/TMTC1/2/3/4-/- cells. (A) HEK293T cells expressing TMTC1, 2, 3 
or 4 were harvested in isotonic buffer and homogenized. A portion of the cell 
homogenate was subjected to ultracentrifugation and resuspended in reducing sample 
buffer. This was considered the total membrane fraction (lanes 1-5). An excess of MNT 
lysis buffer was added to an equal amount of cell homogenate and subjected to S-protein 
agarose affinity purification (lanes 6-10). Proteins were detected by immunoblotting with 
appropriate antisera directed against the S-tag epitope and SERCA2B. (B) S-tagged 
TMTC1, 2, 3 or 4 cDNA was transfected into indicated cell lines. Cell lysates were 
collected and split, one half subjected to treatment with endoglycosidase PNGaseF (lanes 
2, 4, 6, 8 and 10), prior to pulling down glycosylated proteins with Concanavalin A (Con 
A). Samples were then analyzed by 6% SDS-PAGE and immunoblotted with E-cadherin 
antisera to assess levels of glycosylated E-cadherin. (C) Quantification of relative density 
of O-glycosylated E-cadherin from COSMC/POMGnT1/TMTC1/2/3/4-/- cells transfected 
with TMTC1, 2, 3, and 4 cDNA, respectively. Statistical significance between non-




ANOVA. Measurements designated (*) have a P value of <0.05. Error bars represent 
standard deviation. (D) COSMC/POMGnT1/TMTC1/2/3/4-/- cells were transfected with 
S-tagged TMTC3 cDNA. Cell lysate was collected and subjected to a glycosylation assay 
with either PNGaseF (lane 2) or combined PNGaseF and α1-2,3,6 mannosidase treatment 
(lane 3) prior to affinity purification of glycosylated proteins by Con A. Samples were 
then analyzed via 9% SDS-PAGE and immunoblotted with E-cadherin antisera. Error 








Figure 2.6. Deletion of TMTCs and E-cadherin. (A) Expression and stability of E-
cadherin was assessed in O-mannosyltransferase knockout cells to determine effects of 
O-glycosylation. HEK293 COSMC/POMGnT1-/-, HEK293 
COSMC/POMGnT1/POMT1/2-/- and HEK293 COSMC/POMGnT1/TMTC1/2/3/4-/- cells 
were lysed and total protein amount was assessed via Bradford assay. Equal amounts of 
protein were subjected to pull-down via Con A prior to samples being analyzed by 9% 
SDS-PAGE and immunoblotted with E-cadherin antisera to monitor levels of E-cadherin. 
(B) Previously described cell lines were treated with 100 μg/mL cycloheximide for 
indicated time (0, 2, 4, 8, 16 and 24 hr) prior to lysis, total protein quantification and 
subsequent affinity purification with Con A. Samples were then analyzed by 9% SDS-
PAGE (left panel) and the amount of E-cadherin remaining at 2, 4, 8, 16 and 24 hr was 
quantified and normalized to the starting material (0 h) (right panel). Error bars represent 







Figure 2.7. TMTC3 enhances E-cadherin mediated cellular adherence. (A) Cellular 
localization of cadherins was investigated by confocal microscopy. HEK293 
COSMC/POMGnT1-/-, COSMC/POMGnT1/POMT1/2-/- and 




antisera. Scale bars correspond to 50 µm. (B) Adherence was assessed in previously 
described cell lines. Cells were resuspended in growth media and 1 x 106 cells were 
subsequently plated in a 24-well plate. Cells were allowed to adhere for 30 min. 
Unadhered cells were collected and adhered cells were trypsinized and collected. The 
data describes the % of floating (unadhered) cells over the total (unadhered + adhered) 
after counting both fractions. Statistical significance between cell types was calculated by 
one-way ANOVA. Measurements designated (**) have a P value of <0.01. Error bars 
represent the standard deviation. (C) TMTC1, 2, 3 or 4 cDNA was transfected into 
COSMC/POMGnT1/TMTC1/2/3/4-/- cells and adherence was assessed as described in B. 
The increase or decrease of adherence of cells transfected with TMTC1, 2, 3 or 4 was 
established by subtracting the % of mock transfected adhered cells (red dashed line) from 
the % of adhered, transfected cells (adhered/ (unadhered + adhered)). Error bars represent 
the standard deviation. (D) Cellular adherence to immobilized E-cadherin was assessed 
via immunoassay. HEK293 COSMC/POMGnT1-/-, POMT1/2-/-, TMTC1/2/3/4-/- cells and 
TMTC1/2/3/4-/- cells transfected with TMTC3 were resuspended and 60,000 cells were 
placed on immobilized E-cadherin (50 µg/mL). Cells were allowed to attach for 1 hr prior 
to fixing with PFA, permeabilization with triton X-100 and staining with Hoescht. 
Hoescht nuclear staining and DIC images (pictured) were acquired at 40X magnification. 
Scale bars correspond to 50 µm. (E) The number of cells adhered to E-cadherin in 
previously described cell lines was estimated by averaging 5 randomized images 
capturing nuclei intensity at 405 nm within each well from three independent 







Figure 2.8. TMTC3 disease variant predictive outcomes and carbohydrate analysis. (A) 
The organization of TMTC3 WT and disease variants signal sequence (black), 
hydrophobic domains (blue), TPR domains (orange). N-linked glycosylation sites are 
indicated by small black, branched structures. Mutations are indicated in blue. (B) 
HEK293T cells were transfected with S-tagged TMTC3 WT and disease variants cDNA 
as indicated and were affinity purified from the media and the lysed cells using S-protein 
agarose. Samples were then subjected to a glycosylation assay with either EndoH (lanes 
2, 5, 8 and 11) or PNGaseF (lanes 3, 6, 9 and 12) digestion as indicated. Reducing sample 








Figure 2.9. Cellular localization of TMTC3 disease variants. Cellular localization of 
TMTC3 disease variants was investigated by confocal microscopy. COS7 cells were 
transfected with TMTC3 disease variant cDNA.  Fixed cells were stained with S-tag, 








Figure 2.10. TMTC3 WT and disease variant stability. (A) HEK293T cells were 
transfected with S-tagged TMTC3 WT or disease variant cDNA as indicated. Cells were 
treated with 100 μg/mL cycloheximide for the indicated time prior to collection, lysed in 
MNT and samples were subjected to affinity purification with S-protein agarose. 
Reducing sample buffer was added and samples were analyzed via 9% SDS-PAGE and 
immunoblotted for the S-tag epitope. Cell lysates were also subjected to precipitation 
with 10% trichloroacetic acid, analyzed via 9% SDS-PAGE and immunoblotted with 
KDEL antisera to determine stability of GRP94 and BiP (WCL). (B) Time points were 
collected at 0, 2, 4, 8, 16 and 24 hr after cycloheximide treatment. The amount of 
TMTC3 protein remaining at 2, 4, 8, 16 and 24 hr was quantified and normalized to the 
starting material (0 h) and averaged from three independent experiments. Error bars 
represent standard error of the mean. (C) HEK293T cells were transfected with S-tagged 
TMTC3 WT or the TMTC3 R488Efs disease variant as indicated. Cells transfected with 
the TMTC3 R488Efs variant were treated with 20 μM MG132 for 12 hr prior to 
collection and lysis in MNT (lane 4). Samples were subjected to affinity purification with 









Figure 2.11. TMTC conservation in commonly studied species and RNA expression in 
Xenopus laevis. (A) Sequence identity (%) of the TMTC proteins in commonly studied 
species was assessed by comparing amino acid sequences of each species listed to the 
human sequence. (B) RNA expression of TMTC1-4 during Xenopus laevis development 
up to stage 40. These expression profiles were based on data collected in the study by 
Session et. al in Nature 2016. (C) Embryos were injected with TMTC3 morpholino at the 
one cell stage approximately 45 min after fertilization. Selected embryos were 
subsequently injected with human TMTC3 RNA (lanes 3, 4, 5, 8, 9, 10 and 11). Non-
injected and indicated injected embryos were collected at stage 12 and resuspended in 
Modified Barth’s Saline (MBS) buffer with 1% triton X-100. Total protein was 
precipitated with 10% trichloroacidic acid, resuspended in reducing sample buffer, 







Figure 2.12. Knockdown of Tmtc3 in developing Xenopus laevis emrbyos affects 
gastrulation. (A) Embryos were injected with 10 ng of morpholinos against TMTC1, 
TMTC2, TMTC3 and TMTC4 at the one-cell stage. The embryos were scored for 
gastrulation when control embryos reached stage 11-12. Embryos were also injected with 
10 ng of TMTC3 morpholino and subsequently injected with S-tagged huTMTC3WT, 
huTMTC3DD>AA, huTMTC3EE>AA, huTMTC3H67D, huTMTC3R71H and huTMTC3G384E at 
the one-cell stage. The embryos were scored as described above. (B) The average of three 
or more independent experiments is plotted on the graph. Statistical significance between 
injection conditions was calculated using one-way ANOVA. Measurements designated 
(***) have a P value of <0.001. The error bars represent the standard deviation to the 




n=43, TMTC2MO n=45, TMTC3MO n=43, TMTC4MO n=40, TMTC3MO + huTMTC3 
n=35, TMTC3MO + huTMTC3DD>AA n=33, TMTC3MO + huTMTC3EE>AA n=30, 
TMTC3MO + huTMTC3H67D =28, TMTC3 MO + huTMTC3R71H n= 22 and 











Figure 2.13. Putative active sites of TMTC3. (A) S-tagged TMTC1, 2, 3 or 4 cDNA was 
transfected into HEK293 COSMC/POMGnT1/TMTC1/2/3/4-/- cells. Cell lysates were 
collected and one third was subjected to affinity purification with S-protein agarose. 
Samples were then analyzed by 6% SDS-PAGE and immunoblotted for the S-tag epitope 
to assess levels of TMTC1, 2, 3 and 4, respectively. (B) HEK293 
COSMC/POMGnT1/TMTC1/2/3/4-/- cells were transfected with S-tagged TMTC3 WT or 
putative active site mutant (DD>AA or EE>AA) cDNA. Lysates were collected and split, 
one third subjected to treatment with endoglycosidase PNGaseF (lanes 2, 4, 6, 8 and 10), 
prior to pulling down glycosylated proteins with Con A. One third was subjected to 




PAGE and immunoblotted with E-cadherin antisera (top blot) or S-tag antisera to assess 
levels of TMTC3 (lower blots). Lower panel represents the upper panel S-tag blot at a 
higher exposure to see the diminished expression of the DD>AA mutant (lane 3) (C) 
HEK293T cells were transfected with S-tagged TMTC3 WT or putative active site 
mutant cDNA as indicated. Cells were treated with 100 μg/mL cycloheximide for the 
indicated time prior to collection in lysis buffer. Samples were subjected to affinity 
purification with S-protein agarose and analyzed via 9% SDS-PAGE and immunoblotted 
for the S-tag epitope. Time points were collected at 0, 2, 4, 8, 16 and 24 hr after 
cycloheximide treatment. The amount of TMTC3 protein remaining at 2, 4, 8, 16 and 24 
hr was quantified and normalized to the starting material (0 h) and averaged from three 






TTC17 IS A NOVEL ER ADAPTOR INVOLVED IN ER STRESS 
3.1 Abstract 
The endoplasmic reticulum (ER) is a complex, multi-functional organelle, 
comprised of a continuous membrane and lumen that is organized into several functional 
regions with various roles including protein translocation, folding, quality control, 
secretion and the unfolded protein stress response (UPR). Total cellular protein 
homeostasis is maintained by a complicated chaperone network. Bioinformatic 
categorization of the various chaperome factors into functional families revealed that the 
largest family consists of proteins containing tetratricopeptide repeats (TPRs). TPRs are 
well-studied structural motifs that support intermolecular protein-protein interactions. 
TTC17 was identified by an in silico search for TPR-containing proteins that are 
predicted to possess an ER targeting signal sequence. Confocal microscopy and 
carbohydrate analysis revealed that TTC17 acquires a number of N-linked glycans and 
resides in the ER. TTC17 was determined to be a soluble protein within the ER lumen by 
alkaline extraction and trypsin protection assays performed on ER-derived microsomes. 
Immunofluorescence staining and immunoblotting of endogenous TTC17 found it to be 
highly up-regulated in cells that also show higher expression levels of ER chaperones 
BiP, GRP94 and GRP170. Transcript regulation analysis demonstrated that it is 
significantly up-regulated by chemically induced ER stress and cellular protein levels 
were markedly increased in a mutant cell line that undergoes adaptive stress and is grown 
at an elevated temperature. Since TTC17 lacks an ER retention sequence, it is likely 




uncovered interactions between a C-terminally tagged, overexpressed TTC17 and a 
number of ER resident chaperones. Given that TTC17 is regulated by ER stress as are 
many of the chaperones it putatively interacts with, it is possible that TTC17 acts as an 
adaptor protein to spatially and/or temporally coordinate chaperones under cellular stress 
conditions. 
3.2 Introduction 
The endoplasmic reticulum (ER) is an essential compartment for protein 
biosynthesis and maturation within the cell (Ni and Lee, 2007). It also functions as the 
major storage organelle for Ca2+ and lipid biogenesis. Given the various, essential cellular 
functions that it performs and being comprised of a continuous membrane envelope and 
lumen, it is compartmentalized into numerous functional regions (Graham et al., 2019; 
Lynes and Simmen, 2011). The organization of the ER is directed by extrinsic factors that 
connect the ER to the nuclear envelope, the cytoskeleton, other organelles and plasma 
membrane and by ER resident adaptor proteins (Graham et al., 2019; Levine and 
Loewen, 2006; Voeltz et al., 2002). The adaptor proteins nucleate the formation of large 
protein complexes supporting the compartmentalization of the ER (Carvalho et al., 2006; 
Christianson et al., 2008; Mueller et al., 2008). This organization contributes to the ER’s 
ability to efficiently perform functions in the maturation, quality control and trafficking 
of secretory pathway cargo, calcium regulation and lipid biogenesis (English et al., 2009; 
Hebert and Molinari, 2007; Lynes et al., 2013). The ER is essential to maintaining 
cellular homeostasis, however many questions still remain as to how the organization of 




Tetratricopeptide repeat (TPR) protein structural motifs support protein-protein 
interactions and the nucleation of multi-protein complexes (D’Andrea and Regan, 2003; 
Zeytuni and Zarivach, 2012). TPRs are universally found in all organisms and diverse 
pathways. A TPR motif consists of 34 amino acids that fold into two anti-parallel alpha 
helices (Figure 1.1A). There is no consensus sequence for the TPR and no residue is in 
invariant, however, there is a preference for certain amino acids at defined positions 
(D’Andrea and Regan, 2003). TPR motifs can be found in tandem arrays of 2-16 
sequential motifs (D’Andrea and Regan, 2003; Jiménez et al., 2012). Clusters of three 
TPR tandem motifs are the most common and frequently bind more specific ligands, 
whereas longer stretches of sequential TPRs commonly exhibit more promiscuous 
binding. Adjacent TPR units form a series of repeating antiparallel −helices, yielding an 
overall super-helix structure (Zeytuni and Zarivach, 2012). This super-helix fold forms a 
pair of concave and convex surfaces, which display amino acid variety. This allows TPR-
containing proteins to use different binding surfaces to interact with ligands thus 
contributing to their diversity as a protein-protein interaction motif. The TPR functions in 
a variety of proteins involved in numerous cellular processes such as gene regulation, 
mitosis, regulation of steroid receptor function, virulence, protein import and protein 
homeostasis (Cerveny et al., 2013; Graham et al., 2019).  
A database search predicted that the human genome encodes ~ 280 proteins 
containing TPR motifs (Letunic and Bork, 2018, 2019). Further bioinformatic analysis 
combining extensive literature on biochemical properties of chaperones/co-chaperones 
and protein domain identifier databases to examine the expression of genes encoding 




contribute to maintaining the cellular proteostasis network (Brehme et al., 2014). Among 
the 114 TPR-containing proteins predicted to be co-chaperones, eight of the nine 
identified ER localized proteins are included (Figure 1.2). The list excludes SEL1L most 
likely due to the difference in TPR consensus sequence length (Mittl and Schneider-
Brachert, 2007). Additionally, ERdj6 is included in the Heat Shock Protein (HSP)40 
category as the groups were prioritized by chaperone categories rather than localization 
(Brehme et al., 2014). TMTC1-4, TTC13 and TTC17 are included in the TPR co-
chaperone family although they have not yet been shown to function as co-chaperones 
nor their cellular localization been determined. Until recently, SEL1L, ERdj6 and FICD 
were the only ER TPR-containing proteins characterized in mammalian cells (Gardner et 
al., 2000; Rutkowski et al., 2007; Sanyal et al., 2015) and all three proteins are critical for 
maintaining ER proteostasis as they are up-regulated under stress conditions and interact 
with the ER HSP70 paralog, BiP (Christianson et al., 2008). TMTC1-4 are novel 
transmembrane TPR-containing proteins most recently shown to localize to the ER (Li et 
al., 2018; Racapé et al., 2011; Sunryd et al., 2014). They have been suggested to function 
as O-mannosyltransferases of the cadherin family of proteins and shown to be involved in 
calcium regulation. Deletion of Tmtc4 in mice has also been shown to activate the 
unfolded protein response (UPR) (Li et al., 2018). 
Any disruption of ER function, including Ca2+ dysregulation, metabolic disorder 
like hypoxia, viral infection or inhibition of protein folding like glycosylation or disulfide 
bond formation, results in the accumulation of unfolded or misfolded proteins (Ni and 
Lee, 2007). This leads to ER stress, which is defined as an imbalance between cellular 




stress, the cell triggers the UPR. This initiates transient attenuation of protein translation, 
degradation of misfolded proteins as well as the induction of molecular chaperones and 
folding enzymes to augment the ER capacity for protein folding and degradation. The ER 
contains numerous molecular chaperones that are physiologically involved in post-
translational modification, disulfide bond formation, folding assembly and quality control 
of newly synthesized proteins to preserve cellular homeostasis. Upon ER stress, the up-
regulation of these proteins is pivotal for cell survival. 
Here, an in silico approach was used to expand our understanding of ER adaptors 
that participate in the organization of the ER using TPR motifs. TTC17 was identified as 
a TPR-containing protein that possesses a potential N-terminal ER targeting sequence. 
Characterization of endogenous TTC17 and transiently expressed S-tagged TTC17 found 
it to be a soluble protein that resides in the ER lumen. Examination of its transcript 
regulation revealed that TTC17 is significantly up-regulated under ER stress conditions at 
similar levels of previously characterized ER TPR-containing proteins, SEL1L, ERdj6 
and FICD. Furthermore, endogenous TTC17 is up-regulated under heat stress in cells that 
display an adaptive ER stress response. A shot-gun proteomics approach was employed 
that identified numerous ER chaperones as potential interacting partners of TTC17, 
indicating that it may act as a scaffold adaptor to spatially regulate major molecular 
chaperones. Collectively, these findings showed that TTC17 is a novel TPR-containing 
adaptor protein involved in ER stress. 
3.3 Results 




As adaptor proteins commonly use clusters of TPR motifs to modulate protein-
protein interactions and TPR-containing proteins are implicated heavily in co-chaperone 
function, we hypothesize that the ER might contain TPR-containing proteins, in addition 
to SEL1L, ERdj6, FICD and TMTC1-4, that contribute to chaperone organization. In 
silico analysis, using SignalP4.0, TargetP1.1, ΔG and domain architecture database 
SMART7, indicated that TTC17 (NCBI Accession #NP_060729.2 
(http://www.ncbi.nlm.nih.gov/protein/NP_060729.2)) contained a potential N-terminal 
signal sequence and eight TPR motifs (Figure 3.1A) (Emanuelsson et al., 2000; Hessa et 
al., 2007; Letunic and Bork, 2018; Nielsen, 2017; Nielsen et al., 1997, 2019).  
Cellular localization of endogenous TTC17 was determined by a glycosylation 
assay and immunofluorescence confocal microscopy. Secretory proteins are commonly 
modified in the ER with N-linked glycans at the consensus site Asn-Xxx-Ser/Thr. TTC17 
possesses twelve (Homo sapien, human) or eleven (Cricetulus griseus, hamster) predicted 
N-linked glycosylation consensus sites, respectively (Figure 3.1A), therefore a 
glycosylation assay was used to further analyze ER targeting and localization (Gupta, 
2002). As the molecular weight of an N-linked glycan is ~ 2.5 kDa, the removal of N-
linked glycans by glycosidase treatment results in a corresponding increase in mobility 
for the deglycosylated protein. Endoglycosidase H (Endo H) trims the high mannose 
glycans encountered in the ER while Peptide-N-Glycosidase F (PNGase F) removes 
complex glycans acquired in the Golgi in addition to high mannose glycans.  
Wild type (WT) chinese hamster (Cricetulus griseus) ovary (CHO) cell lysate and 
media fractions were collected and subjected to glycosidase treatment. A shift upon 




targeted to the ER and received N-linked glycans. A similar increase in mobility was 
observed upon Endo H treatment (Figure 3.1B, lane 2) demonstrating that the 
carbohydrates were high mannose glycoforms suggesting that TTC17 is an ER resident 
protein (Figure 3.1B).  
To biochemically characterize human TTC17, cDNA was subcloned into a 
mammalian expression vector harboring a C-terminal S-tag, and its localization was 
assessed by the same methods. HEK293T cells were transfected with TTC17 S-tag, and 
cell lysate and media fractions were affinity precipitated with S-protein agarose beads 
followed by glycosidase treatment. A shift upon PNGaseF treatment (Figure 3.1C, lane 3) 
was observed for TTC17 S-tag indicating that it was targeted to the ER and received N-
linked glycans. A similar increase in mobility was observed upon Endo H treatment 
(Figure 3.1C, lane 2) signifying that the carbohydrates were high mannose glycoforms 
consistent with human S-tagged TTC17 being an ER resident protein (Figure 3.1C).  
WT CHO cells were immunostained for endogenous TTC17 and staining was 
compared against an ER (KDEL) or Golgi (GM130) marker (Figure 3.1D). TTC17 co-
localized with ER marker, KDEL, while co-localization was not observed with GM130 
(Figure 3.1D). C-terminally S-tagged human TTC17 was similarly assessed for 
localization and also co-localized with KDEL and not GM130 (Figure 3.1E). Therefore, 
the glycosylation profiles and the cellular distribution are consistent with both human and 
hamster TTC17 residing in the ER.  
3.3.2 TTC17 is a soluble protein that resides within the ER lumen 
Analysis of the TTC17 protein sequence with ΔG prediction demonstrated that it 




the ER lumen (Figure 3.1A). Alkaline extraction and a protease protection assay were 
performed on isolated membrane fractions to determine if TTC17 is a soluble protein 
residing within the ER lumen (Mostov et al., 1981).  
WT CHO cells were homogenized in isotonic buffer and fractions were separated 
by centrifugation. TTC17 was found enriched in the whole cell lysate (WCL) and total 
membrane (TM) fractions (Figure 3.2A, lanes 1 and 4). Alkaline extraction of the total 
membrane fraction followed by centrifugation found TTC17 enriched in the supernatant 
fraction (S) (Figure 3.2A, lane 5). This profile was observed for the ER soluble protein, 
Glucosidase II, and not the membrane bound protein calnexin, which appeared 
exclusively in the pellet (P) (Figure 3.2A, lanes 5 and 6). Therefore, TTC17 is a soluble 
protein.  
Additionally, a protease protection assay was employed to confirm that TTC17 
resides in the ER lumen. First, alkaline extraction was performed as previously described 
in HEK293T cells expressing human TTC17 S-tag to show that it was also a soluble 
protein (Figure 3.2B, lane 5). Next, HEK293T cells were transfected with a human 
TTC17 construct containing a C-terminal S-tag, and cells were homogenized prior to 
isolation of ER-enriched microsomes. Isolated microsomes were resuspended in an 
isotonic buffer, and aliquots were treated with triton X-100 and the protease, trypsin, as 
indicated. Trypsin treatment did not appear to cleave TTC17 (Figure 3.2C, compare lane 
1 to 3). As the S-tag is at the C-terminus, this demonstrated that TTC17 was positioned in 
the ER lumen. Combined with the modification of the glycosylation sites (Figure 3.1B 
and C), these results demonstrated that TTC17 is a soluble ER protein. 




Proteins that reside in the secretory pathway are frequently transcriptionally up-
regulated by stress (Walter and Ron, 2011). Of the nine TPR-containing proteins that 
localize to the ER, four have been shown to be transcriptionally up-regulated by stress; 
including SEL1L, ERdj6, FICD and TMTC4 (Christianson et al., 2008; Li et al., 2018; 
Rutkowski et al., 2007; Sanyal et al., 2015). To determine whether TTC17 is 
transcriptionally regulated by ER stress, HEK293A cells were exposed to different ER 
stress conditions induced by various pharmacological compounds. Cells were subjected 
to N-glycan synthesis inhibition (tunicamycin), calcium depletion (thapsigargin), redox 
stress (dithiotreitol, DTT), inhibition of anterograde protein trafficking (brefeldin A) or 
proteasomal inhibition (MG132). RNA was harvested from cells followed by reverse 
transcription to generate cDNA and changes in gene expression were measured by qRT-
PCR.  
TTC17 gene expression was significantly increased with tunicaymycin, 
thapsigargin, brefeldin A and MG132 treatment by ~ 7.1, 4.6, 8.9 and 2.4-fold, 
respectively (Figure 3.3B). TTC17 was also up-regulated ~1.6-fold by DTT. BiP was 
significantly stimulated by all treatments at ~10.7, 82.3, 4.9, 24.5 and 12.5-fold for 
tunicamycin, thapsigargin, DTT, brefeldin A and MG132 treatment, respectively. In 
addition, the assessment of basal mRNA levels revealed that TTC17 mRNA is expressed 
at ~ 1.3% of the reference gene -actin whereas ER resident chaperone, BiP, is ~ 20% of 
 -actin (Figure 3.3A). As expected, BiP basal mRNA levels are far more elevated than 
TTC17 as BiP is one of the most abundant proteins in the ER and is tightly regulated to 
maintain cellular homeostasis (Pobre et al., 2018). Interestingly, SEL1L, ERdj6 and FICD 




induced by ER stress (Figure 3.3B). TTC17 is significantly up-regulated by several forms 
of stress like these ER co-chaperones and ERAD components, suggesting that it may be 
involved in the ER stress response as the other three proteins have been shown to be 
(Rutkowski et al., 2007; Sanyal et al., 2015; Sun et al., 2014). 
3.3.4 Endogenous TTC17 and ER chaperones show elevated expression levels in 
cells 
BiP is one of the most abundant proteins in the ER, along with the ER Hsp90 
paralog, GRP94, collagen specific chaperone HSP47, cyclophilin B, lectin binding 
chaperone calreticulin, PDI and ERp57 (Gidalevitz et al., 2013). The ER chaperones can 
be categorized into three groups: (1) chaperones of the heat shock protein (HSP) family 
including GRP78/BiP, GRP94 and their co-chaperones; (2) chaperone lectins like 
calnexin, calreticulin and EDEMs; and (3) substrate-specific chaperones such as HSP47 
(Ni and Lee, 2007). Given that TTC17 was identified as a likely co-chaperone within the 
largest functional family of the cellular chaperone network, we examined its expression 
in cells by immunofluorescence confocal microscopy (Brehme et al., 2014).  
WT CHO cells were immunostained for endogenous TTC17 and staining was 
compared against endogenous BiP, GRP94 and co-chaperone/nucleotide exchange factor, 
GRP170 (Figure 3.4). TTC17 co-localized with each protein, and interestingly showed 
similar elevated expression levels (Figure 3.4). By observation, ~ 1-5% of cells showed 
elevated expression of these chaperone family members suggesting that TTC17 along 





In order to determine why these proteins were elevated in a low percentage of 
cells, immunostaining was performed on cells under a number of conditions and any 
significant change in expression of TTC17 was noted. BiP and GRP94 are not only up-
regulated during protein folding stress, but they are up-regulated under a number of 
cellular stresses including calcium dysregulation, during cell cycle check points and 
signal transduction (Adomako et al., 2015; Dudek et al., 2009). Cells were treated with 
the pharmacological ER stress inducer compounds including tunicamycin (N-glycan 
synthesis inhibition), thapsigargin (calcium depletion), dithiotreitol, DTT (redox stress), 
brefeldin A (inhibition of anterograde protein trafficking) or MG132 (proteasomal 
inhibition) (Figure 3.3B) as well as compounds that synchronized the cells in the G0 
phase of the cell cycle (retinoic acid), serum starvation and amino acid starvation. 
Change in TTC17 expression was not observed under any of these treatments (data not 
shown). Interestingly, when we assessed TTC17 expression in a genetically manipulated 
CHO cell line (MI8-5) that undergoes adaptive stress, a significant increase was observed 
(Figure 3.5A, lower panel). MI8-5 cells are mutagenized CHO cells that resulted from a 
mannose suicide selection screen using temperature sensitivity (Quellhorst et al., 1999). 
MI8-5 cells were shown to produce unglucosylated N-linked glycans, resulting from a 
mutation in the ALG6 gene. Normally, N-linked glycans are assembled prior to en bloc 
transfer of a Glc3-Man9-GlcNAc2 carbohydrate branch to a translocating polypeptide by 
the oligosaccharyltransferase (OST) complex (Tannous et al., 2015). The glycans in MI8-
5 cells are successfully transferred onto folding secretory proteins, however, they were 
missing the three terminal glucoses. The terminal glucoses are critically important for 




et al., 2010). As glycoproteins could not initially engage this chaperone system for 
productive folding, ER stress was induced (Pearse et al., 2008). Interestingly, the cells 
continued to grow under adaptive stress at the permissive temperature of 34 ºC, whereby 
the UPR is continually induced as XBP-1 is cleaved, but chaperone levels are not up-
regulated over WT.  
The original selective mannose screen for MI8-5 cells used temperature 
sensitivity to select for defects at an elevated temperature (40.5 ºC), however, MI8-5 cells 
did not survive at this temperature. Therefore, TTC17 expression was assessed at 37 ºC, 3 
ºC higher than their normal growth temperature. First, transcript levels of TTC17 were 
determined in WT CHO and MI8-5 cells at different growth temperatures (Figure 3.5B). 
RNA, harvested from cells grown under normal conditions, was reverse transcribed to 
generate cDNA and changes in gene expression were measured by qRT-PCR. TTC17 was 
elevated in both WT CHO and MI8-5 cells grown at 37 ºC by ~ 2.2 and 1 % higher, 
respectively, than TTC17 in cells grown at 34 ºC (Figure 3.5B). Both immunostaining 
and immunoblotting showed significantly elevated expression of TTC17 in MI8-5 cells 
grown at 37 ºC (Figure 3.5A, C and D). The immunoblots and immunofluorescent images 
also revealed slightly elevated levels of the ER HSP chaperones, BiP and GRP94 (Figure 
3.5 A and C). Based on this data, there appears to be a correlation between the elevated 
expression of chaperones and TTC17, however further analysis is required to understand 
the relationship. 
3.3.5 TTC17 interacts with a number of chaperones 
 To identify binding partners of TTC17, a shot-gun liquid chromatography-mass 




expressing TTC17 with a C-terminal S-tag were homogenized and ER-derived 
microsome fractions were isolated. Proteins associated with TTC17 were isolated using 
the S-protein agarose beads and resolved by SDS-PAGE. The gels were subjected to 
either silver staining or in-gel trypsin digestion followed by LC-MS/MS analysis (Figure 
3.6A). The proteins associated with S-tagged TTC17 obtained from the LC-MS/MS 
analysis are listed in Figure 3.6C. The LC-MS/MS results indicated possible interactions 
for TTC17 with ~ 8 chaperones, including GRP94 and BiP.  
 To verify the interactions identified using the mass spectrometry approach, 
HEK293T cells were transfected with C-terminal S-tagged TTC17, followed by affinity 
purification and immunoblotting against endogenous associated proteins. Although an 
interaction with the ER HSP chaperones was not validated via immunoblotting, a 
transient interaction could still take place, but further analysis is required. Interestingly, 
TTC17 interacted with glycoprotein folding sensor UDP-glucose:glycoprotein-
glucosyltransferase (UGGT1) (Figure 3.6B, lane 4) as did other S-tagged UPR induced 
ER proteins TMTC4, SEL1L and EDEM1 (Figure 3.6B, lanes 5, 6 and 7). The interaction 
between TTC17 and UGGT1 could be due to the extensive glycosylation of TTC17. 
UGGT1 acts a gatekeeper of the secretory pathway quality control system (ERQC), 
querying folding substrates for secretion if deemed correctly folded or re-glucosylation of 
their N-linked glycans so they may re-engage the carbohydrate binding chaperones 
calnexin and calreticulin (Tannous et al., 2015). TTC17 is a large protein that is heavily 






 Here, we identified and characterized a novel TPR-rich ER protein, TTC17. Our 
data shows that TTC17 is an extensively glycosylated, soluble ER resident protein that is 
transcriptionally up-regulated by ER stress. Endogenous expression was also shown to be 
elevated in a small percentage of cells and this expression level corresponded to elevated 
levels of ER chaperones, BiP, GRP94 and GRP170. The percentage of cells displaying 
up-regulated levels of TTC17 and chaperones increased significantly in a constitutively 
stressed mutant cell line, MI8-5. Furthermore, it was determined that growing the mutant 
cells at a higher temperature, possibly inducing heat stress, contributed to the increased 
expression of TTC17. Proteomic analysis of affinity precipitated TTC17 protein 
complexes showed that TTC17 putatively interacts with a number of ER resident 
chaperones, including BiP and GRP94. Together, this data along with bioinformatic 
analysis suggests that TTC17 may act as a classic TPR co-chaperone to ER resident 
chaperones, regulating their organization or function under ER stress conditions. 
 Basic Local Alignment Search Tool (BLAST) analysis indicated that TTC17 
homologues are conserved in the chordata phylum, however, they are absent in lower 
eukaryotes, such as yeast, and RNA-sequencing data shows that it is expressed in a 
number of tissues (Brini and Carafoli, 2009; Uhlén et al., 2015). Published data has 
demonstrated that TTC17 interacts with C2orf62 in the cytoplasm and is involved in actin 
organization and ciliogenesis within zebrafish (Bontems et al., 2014). Although the 
localization of TTC17 in this work shows it to be in the cytoplasm, which is contrary to 
our findings of TTC17 being an ER resident protein, the interaction between TTC17 and 
C2orf62 was determined using only a small GST-tagged purified region of TTC17 (aa 




antibody used to show cellular localization (HPA038508) recognizes TTC17 in the ER in 
rodent cells, however, it also recognizes cytoskeletal filaments, which could explain 
cytoplasmic localization and actin association.  
Among the novel ER-TPR containing proteins identified by an in silico search, 
TTC17 transcripts are the most significantly up-regulated by ER stress. Interestingly, the 
basal mRNA levels and fold induction under stress conditions is very similar to that of 
previously characterized ER TPR-containing proteins ERdj6, FICD and SEL1L. All four 
proteins are significantly up-regulated by calcium dysregulation, which has been shown 
to readily lead to ER stress. A number of ER-trafficked and resident proteins are 
dependent upon calcium binding for function and thus any mis-regulation not only 
induces total cellular signaling responses but also reduces the capacity of the ER to 
properly perform folding functions (Ashby and Tepikin, 2001).  In addition to its 
transcriptional up-regulation by pharmacologically induced ER stress, endogenous 
TTC17 was highly up-regulated in genetically mutated cells constitutively under adaptive 
stress. Furthermore, the expression of TTC17 was increased when the growth 
temperature of these cells was increased, as was the expression of ER HSP chaperones 
BiP and GRP94. Although, BiP and GRP94 belong to the HSP family, neither ER 
localized paralogs possess heat shock elements (HSEs) within their promoters, thus are 
not known to be regulated by heat stress (Casas, 2017; Mahat et al., 2016). Interestingly, 
studies in yeast have shown that a number of ER localized proteins are up-regulated by 
the heat shock response under conditions of existing ER stress, thus providing a potential 




As mentioned previously, the cellular HSP70s and HSP90s are highly abundant 
and highly regulated within cells demonstrating their importance to maintaining cellular 
homeostasis. A number of TPR-containing proteins have been shown to act as co-
chaperones of these chaperone family members, aiding in spatial organization and 
function for maximum efficiency (Assimon et al., 2015). ERdj6 and FICD are known 
TPR-containing co-chaperones of BiP. ERdj6 interacts with BiP through its J-domain and 
the TPRs have been shown to bind unfolded substrate (Rutkowski et al., 2007). 
Interestingly, ER stress reduces the efficiency of ERdj6 translocation into the ER leading 
to accumulation of the protein in the cytosol. This cytosolic pool functions to modulate 
translation in response to cellular stresses. FICD also interacts with BiP through its FIC 
domain and reversibly modifies BiP by AMPylation, which affects BiPs activity 
(Preissler et al., 2015). FICD expression is up-regulated under stress conditions, whereby 
it quickly de-AMPylates BiP thus creating a readily available, active pool of the 
chaperone when misfolded or unfolded proteins have accumulated. It is not yet 
understood what FICD’s two TPR motifs interact with and how they contribute to 
FICD’s function. Both FICD and ERdj6 aid to modulate BiPs activity under changing 
cellular conditions. Although BiP is actively transcribed upon the induction of the UPR, 
enhancing the activity of the BiP protein that is already present within the ER is an 
efficient method of rapidly attenuating folding stress.  
One of the most well characterized TPR-containing co-chaperones is HOP, the 
Hsp70/Hsp90 Organizing Protein, which acts as a bridging chaperone binding both 
cytosolic HSP90 and HSP70 for efficient client transfer between chaperone systems 




their C-terminal tails. An ER bridging co-chaperone has yet to be identified, but TTC17 
may be a candidate. HOP possesses three clusters of three TPR motifs each, one of which 
interacts with the cytosolic HSP70 (TPR1) and another TPR cluster (TPR2A) interacts 
with HSP90. All TPR clusters in HOP recognize the four C-terminal residues of 
HSP70/90, EEVD, and bind via carboxylate clamp. Other TPR-containing proteins have 
also been shown to interact with HSP70/90 in a similar manner using clusters of three 
and four consecutive TPRs to bind the C-terminal EEVD chaperone motif, such as 
TOM70 and SGTA (Roberts et al., 2015; Young et al., 2003). Chaperones of the ER 
possess a C-terminal retention sequence, Lys-Asp-Glu-Leu (KDEL), that could 
potentially act as a ligand for a co-chaperone like TTC17. 
TTC17 possesses two predicted clusters of three and four sequential TPR motifs, 
respectively. Predictive modeling and electrostatic mapping of these two clusters show 
that they both possess a patch of positive residues lining the concave surface and could 
therefore attract negatively charged residues, like the Asp and Glu (DE) in KDEL (Figure 
3.7). Analysis of the shot-gun proteomics results showed that many of the chaperones (~ 
40%) that putatively interact with TTC17 possess a C-terminal KDEL, or similar charge 
sequence (i.e. HDEL, RDEL, HDEF, HEEF, and REEL) (Figure 3.6C). Surprisingly, 
only 18 proteins within the human proteome contain a C-terminal KDEL and all are ER 
resident. Since there are far more ER resident proteins than 18, it is possible that the other 
proteins might possess a similar charge sequence and be retained by KDEL receptors or 
sequestered in the ER by another protein, possibly TTC17 (Bräuer et al., 2019). 
Additionally, it is possible that TTC17 interacts with a short sequence on ER chaperones 




homeostasis cues. Further studies are necessary to better understand what part of TTC17 
is responsible for interacting with chaperones and under what cellular conditions do these 
interactions take place. 
3.5 Materials and Experimental Procedures 
3.5.1 Plasmids and reagents 
Dulbecco's modified Eagle's medium (DMEM), MEM GlutaMax, fetal bovine 
serum, penicillin and streptomycin were purchased from Invitrogen/ThermoFisher 
Scientific. Easy-Tag [35S]-Cys/Met was purchased from PerkinElmer Life Sciences. S-
protein-agarose beads and S-tag antibody were purchased from EMD Millipore. Endo H, 
PNGase F, Protoscript II first strand cDNA synthesis kit and all cloning reagents were 
purchased from New England Biolabs. FastStart SYBR Green qPCR mix was purchased 
from Roche Diagnostics, and all primers were acquired from IDT DNA. IRDye® 800CW 
Goat anti-Mouse IgG, IRDye® 680RD Goat anti-Rabbit IgG and IRDye® 680RD 
Donkey anti-Goat IgG were purchased from Li-COR Biosciences. Antibodies directed 
toward the following antigens were also purchased: calnexin (Enzo Life Sciences); 
Glucosidase II (ThermoFisher Scientific); GRP94 (ThermoFisher Scientific); TTC17 
(SCBT); BiP (gift from Dr. Linda Hendershot), GRP170 (gift from Dr. Linda 
Hendershot); -tubulin (Cell Signaling Technologies); GM130 (BD Biosciences) and 
KDEL (Enzo Life Sciences). TTC17 cDNA was created by isolating RNA (HEK293T 
cells) and cloned into pcDNA3.1 A−, a plasmid harboring a C-terminal S-tag, using 
standard molecular biology techniques. All other chemicals were obtained from Sigma.  




HEK293T, 293A or COS7 cells were grown in DMEM supplemented with 10% 
fetal bovine serum, 100 U/mL penicillin and 100 mg/ml streptomycin. WT CHO and 
MI8-5 cells were grown in MEM GlutaMax supplemented with 10% fetal bovine serum 
and 100 U/mL penicillin and 100 mg/ml streptomycin.  
3.5.3 In silico analysis of TTC17 
The primary amino acid sequence of TTC17 was analyzed by UniProtKB and 
TPRpred to identify the number and position of putative TPR domains (Karpenahalli et 
al., 2007, 2019). Hydrophobic regions were identified by the ΔG software, which predicts 
transmembrane domains (Hessa et al., 2007). Putative N-linked glycosylation sites were 
identified by NetNGlyc4.0 (Gupta, 2002).  
3.5.4 Affinity Purification and glycosylation assay 
Transfected cells were lysed in NP-40 buffer (1% NP-40, 150 mM NaCl, 50 mM 
Tris-HCl [pH 8.0]). All steps were conducted at 4 C. The post-nuclear supernatant 
(PNS) was isolated by centrifugation followed by either direct glycosidase treatment with 
appropriate enzymes and buffers prior to trichloroacetic acid precipitation or pre-clearing 
with un-conjugated agarose beads for 1 hr. Cleared supernatant was incubated with S-
protein agarose beads overnight and subsequently washed twice with wash buffer (0.1% 
NP-40, 150 mM NaCl, 50 mM Tris-HCl [pH 8.0]). After the final wash, glycosylation 
assays were performed by adding appropriate buffers and either mock, Endo H or 
PNGase F enzymes according to the manufacturer’s protocol. Finally, reducing sample 
buffer was added to all samples and they were analyzed by SDS-PAGE.  




Cells were fixed with 3.7% paraformaldehyde in phosphate buffered saline (PBS) 
for 15 min followed by permeabilization with 0.1% triton X-100 for 15 min at 25 C. If 
cells were transfected with TTC17 S-tag cDNA, the transfection was performed 
approximately 16 hr prior to fixing. Slides were stained with the indicated primary 
antibodies followed by staining with appropriate Alexa Fluor 488 or 594 secondary 
antibodies in immunostaining buffer (10% fetal bovine serum in 1X PBS). Slides were 
rinsed and mounted onto cover slips with VectaShield (Vector Laboratories). Images 
were obtained with a Fluoview 1000 MPE, 1X81 motorized inverted research microscope 
(Olympus Inc.) equipped with a Hamamatsu C8484-05G camera. All images were 
acquired with a Plan Apo N 60x 1.42NA lens and processed by using the FV10-ASW and 
Adobe Photoshop software.  
3.5.6 Alkaline extraction 
Alkaline extraction was performed as previously described (Sunryd et al., 2014). 
Briefly, cells were resuspended in ice-cold homogenization buffer (20 mM HEPES, 5 
mM KCl, 120 mM NaCl, 1 mM EDTA, and 0.3 M sucrose [pH 7.5]) and passed through 
a 25-gauge needle 20-times. All subsequent steps were conducted at 4 C. The 
homogenate was centrifuged at 1,000 g for 10 min to pellet the nuclear fraction. The 
remaining PNS was centrifuged at 45,000 rpm in Beckman rotor (TLA 120.2) for 10 min 
to separate the cytosol (supernatant) from the cellular membranes (pellet). The cellular 
membrane fraction was resuspended in homogenization buffer, and a portion of the 
resuspended membranes was incubated with 0.1 M Na2CO3 (pH 11.5) for 30 min on ice. 
The alkaline extracted portion was centrifuged at 65,000 rpm for 20 min through a 




proteins from membrane proteins in the supernatant and pellet, respectively. The pH was 
adjusted in the alkaline extracted sample with 1 M Tris-HCl (pH 7.5). The WCL, Cyt, 
TM and S fractions were precipitated with 10% trichloroacetic acid prior to adding 
reducing sample buffer and analyzing samples via SDS-PAGE.  
3.5.7 Trypsin protection 
Transfected cells were radiolabeled for 1 hr prior to resuspension in cold 
homogenization buffer (10 mM HEPES [pH 7.4], 10 mM KCl, 1.5 mM MgCl, 5 mM 
sodium EDTA, 5 mM sodium EGTA and 0.25 M sucrose) and passed through a 25-gauge 
needle 20-times.  All subsequent steps were conducted at 4 C. The homogenate was 
centrifuged at 1,000g for 10 min to pellet the nuclear fraction. The remaining PNS was 
centrifuged at 45,000 rpm in Beckman rotor (TLA 120.2) for 10 min to separate the 
cytosol (supernatant) from the cellular membranes (microsomes). The microsomes were 
resuspended in homogenization buffer containing 0.1 M NaCl and 10 µg trypsin and/or 
triton X-100 was added to a final concentration of 0.1%. After incubation at 27 C for 15 
min, the reaction was quenched with 100 µg soybean trypsin inhibitor. Reducing sample 
buffer was added and analyzed via SDS-PAGE.  
3.5.8 Immunoblotting and affinity purification 
Non-transfected and transfected cells were lysed in NP-40 buffer and the post-
nuclear supernatant (PNS) was isolated by centrifugation followed by total protein 
concentration determination using 595 nm Protein Assay Dye Reagent (Bio-Rad). All 
subsequent steps were conducted at 4 C. Equal amounts of total protein were isolated 
from all samples by precipitation with 10% trichloroacetic acid or affinity purification 




and they were analyzed by SDS-PAGE. Proteins were transferred to a polyvinylidene 
difluoride membrane and immunoblotted with the appropriate antisera. Blots were 
developed and TIFF files were acquired using a LI-COR Odyssey CLx Imager. 
Densitometric quantification of western blots was performed using ImageJ software 
(Fiji). The amount of TTC17, BiP and GRP94 was calculated by dividing the amount of 
each protein with the amount of -tubulin. Error bars represent the standard deviation for 
three independent experiments.  
3.5.9 qRT-PCR 
HEK293A cells were treated with regular growth media or dithiothreitol (2 mM) 
for 2 hr or tunicamycin (1 µg/mL), thapsigargin (3 µM), brefeldin A (2.5 µg/mL) and 
MG132 (2.5 µM) for 24 hr prior to RNA isolation with RNAeasy Mini Kit (Qiagen). One 
g of purified RNA was reverse transcribed into cDNA using the Protoscript II Reverse 
Transcriptase kit (New England Biolabs). Quantitative real time polymerase chain 
reactions (qRT-PCR) were performed in 20 µL reactions using the FastStart universal 
SYBR Green master (Rox) kit (Roche diagnostics Corp.) on an Mx3000P real-time PCR 
machine (Agilent Technologies Inc.) according to manufacturer’s instructions. Changes 
in mRNA levels were calculated using the change in cycle threshold value method with 
-actin as the reference gene (Pfaffl, 2001). Statistical analysis of the data was calculated 
using GraphPad Prism 5.0 (GraphPad software) and significance between treatment 
groups was determined using unpaired T-tests.  
 The following primers were used: -actin (5’ GCACTCTTCCAGCCTTCC 3’, 5’ 




 3’, 5’ GTACTCACGATGGCAGTCAG 3’), SEL1L (5’ 
GAGGCCATATCTTGGCTTTCT 3’, 5’ GGCCTCGTTCACATACATTCT 3’) FICD 
(5’ TATGGTGTCTGCTGTGTCTTG, 5’ CTCCTCCACCTTAGTGCAAAT 3’), ERdj6 
(5’ CTTTATGCTGTCTGGAGGGAAG 3’, 5’ GCAAGGCTGTGAAGAGAAGA 3’).  
3.5.10 Shotgun LC-MS/MS and silver stain 
HEK293T cells were transfected as indicated and isolated by isotonic 
fractionation and ultracentrifugation to purify microsomes. These microsomes were then 
resuspended with 1% NP-40 detergent buffer followed by affinity purification with S-
protein agarose beads. Affinity purifications (APs) were washed twice with wash buffer 
containing 0.1% NP-40 and twice in 50 mM ammonium carbonate before adding 
reducing sample buffer. A portion of the sample was loaded onto a SDS-PAGE and 
subjected to silver staining to verify the enrichment of putative binding partners 
(Chevallet et. al Nature Protocols 2006). Once appropriate enrichment had been 
observed, a portion of the AP was loaded onto a SDS-PAGE gel (10-40% bis-tris protein 
gel NuPage), and the dye front was allowed to migrate ~1 cm into the resolving gel. The 
sample containing area of the gel was excised and prepared for in-gel trypsin digestion. 
Tryptic peptides generated by trypsinization were loaded on a LC-MS/MS instrument 
followed by protein identification. Proteins were scored based on the number of unique 








Figure 3.1. TTC17 is an ER resident TPR-containing protein. (A) Our screen for novel 
secretory adapter proteins identified TTC17 as a putative TPR-containing protein that 
was potentially targeted to the ER by an N-terminal signal sequence (black square). The 
position of tetratricopeptide repeats (TPRs) (orange squares) is designated and predicted 
N-linked glycosylation sites are indicated by small, black, branched structures. Human 
TTC17 cDNA was C-terminally S-tagged (blue star) for biochemical studies. The 
hamster and human TTC17 sequences are designated and differ by fifty amino acids as 
indicated by the angled blue lines. (B) WT CHO cell lysate and media was collected and 
subjected to a glycosylation assay with either EndoH (lanes 2 and 5) or PNGaseF (lanes 3 
and 6) digestion as indicated. Reducing sample buffer was added and the samples were 




against endogenous TTC17. (C) HEK293T cells were transfected with S-tagged TTC17 
and TTC17 was affinity purified from the cell lysate and media using S-protein agarose. 
Samples were then subjected to a glycosylation assay with either EndoH (lanes 2 and 5) 
or PNGaseF (lanes 3 and 6) digestion as indicated. Reducing sample buffer was added 
and the samples were analyzed by a 6% SDS-PAGE and immunoblotted for the S-tag 
epitope. (D) Cellular localization of endogenous TTC17 was investigated by confocal 
microscopy. WT CHO cells were fixed cells and stained with TTC17, KDEL (ER) or 
GM130 (Golgi) antisera. Nuclei were visualized by DAPI staining (blue). (E) COS7 cells 
were transfected with human TTC17 cDNA. Fixed cells were stained with S-tag, KDEL 






Figure 3.2. TTC17 is a soluble protein that resides within the ER lumen. (A) WT CHO 
cells were homogenized and fractionated prior to alkaline extraction. The fractions 
collected were whole cell lysate (WCL), nucleus (N), cytosol (C), total membrane (TM), 
as well as supernatant (S) and pellet (P) fractions upon alkaline extraction of the TM. The 
WCL, C, and S fractions were then precipitated with trichloroacetic acid, and all samples 
were resuspended in sample buffer prior to the proteins being detected by 
immunoblotting with antisera directed against TTC17, calnexin (CNX) and Glucosidase 
IIα (αGlucII). (B) HEK293T cells transfected with S-tagged TTC17, homogenized, 
fractionated prior to alkaline extraction and samples collected as described in A. Samples 
were analyzed via 7% SDS-PAGE prior to immunoblotting with antisera against the S-
tag epitope, calnexin (CNX) and Glucosidase IIα (αGlucII). (C) TTC17-S-tag was 
expressed in HEK293T cells. After radiolabeling with [35S]-Cys/Met for 1 hr, cells were 
homogenized, and microsomes were purified by ultracentrifugation then resuspended in 
homogenization buffer. Aliquots of the ER microsomes were incubated for 10 min at 27 
˚C with or without triton X-100 and trypsin as indicated. Samples were subsequently 
subjected to affinity purification using S-protein agarose beads. Samples were resolved 






Figure 3.3. Basal transcript abundance and fold induction of TTC17 by ER stress. (A) 
RNA from HEK293A cells, grown under normal conditions, was harvested. RNA was 
reverse transcribed to cDNA followed by qRT-PCR with appropriate primers. Basal 
mRNA abundance was assessed using β-actin as a reference. Error bars represent 
standard deviation from at least three independent experiments. (B) HEK293A cells were 
treated with regular growth media or with 2 mM DTT for 2 hr, 1 μg/mL tunicamycin, 3 
μM thapsigargin, 2.5 μg/mL brefeldin A or 2.5 μM MG132 for 24 hr prior to RNA 
purification. RNA was reverse transcribed to cDNA followed by qRT-PCR with 
appropriate primers, and changes in gene expression were calculated using β-actin as a 
reference. Statistical significance between treatment groups was determined using an 
unpaired T test. *, ** and *** indicates a P-value of less than 0.05, 0.01 and 0.001, 








Figure 3.4. TTC17 and ER stress chaperones show elevated expression in cells. WT CHO 
cells were fixed and stained with TTC17, BiP, GRP94 and GRP170 antisera. Nuclei were 






Figure 3.5. TTC17 is up-regulated by heat in reglucosylation deficient cells. (A) WT 
CHO and MI8-5 cells were fixed and stained with TTC17 and KDEL (ER) antisera.  
Nuclei were visualized by DAPI staining (blue). (B) RNA from WT CHO and MI8-5 
cells, grown under normal conditions at the temperatures indicated, was harvested. RNA 
was reverse transcribed to cDNA followed by qRT-PCR with appropriate primers. Basal 
mRNA abundance was assessed using β-actin as a reference. Error bars represent 
standard deviation from at least three independent experiments. (C) WT CHO and MI8-5 
cell lysates grown at 34 ºC and 37 ºC, respectively, were collected. Samples were run on 
a 6% SDS-PAGE prior to detection by immunoblotting with antisera directed against 
endogenous TTC17, KDEL and β-tubulin. (D) Quantification of relative density of 
TTC17 from WT CHO and MI8-5 cells grown at indicated temperatures, respectively. 







Figure 3.6. ER localized S-tagged TTC17 interacts with a number of chaperones. (A) A 
shotgun liquid chromatography-mass spectrometry/mass spectrometry (LC-MS/MS) 
approach was used to identify potential binding partners of TTC17. HEK293T cells were 
transfected with TTC17-Stag plasmid followed by isotonic fractionation and 
ultracentrifugation to purify microsomes. The microsomes were resuspended in a buffer 
with detergent, and the tagged protein was affinity purified with S-protein agarose beads. 
The affinity purified complex was run on a short SDS-PAGE prior to in-gel trypsin 
digestion and silver staining. The peptides generated by trypsinization were loaded onto a 
LC-MS/MS instrument followed by peptide identification. Proteins were scored based on 




with S-tagged cDNA of NASP, TTC13, TTC17, TMTC4, SEL1L and EDEM1. Cells and 
media were collected, and S-tagged proteins were affinity purified using S-protein 
agarose. Samples were then subjected to immunoblotting with antisera directed against 
the S-tag epitope and endogenous UGGT1. (C) Potential binding partners identified from 
shot-gun proteomics approach described in (A). The unique number of peptides was 
determined by averaging three independent experiments and then subsequently compared 
to mock. The corrected column represents the difference and is displayed in ascending 
order of number of peptides. The four C-terminal residues for each protein is displayed to 







Figure 3.7. Structural models of TTC17 TPR clusters reveal positively charged patches 
on the concave surface. (A) Surface model (Phyre 2.0) of the first cluster of TPRs (2-4) 
in TTC17 depicting negatively charged residues (red) and positively charged residues 
(blue). (B) Surface model (Phyre 2.0) of the second, C-terminal cluster of TPRs (5-8) in 






CONCLUSIONS AND FUTURE DIRECTIONS 
A bioinformatic screen for novel TPR-containing proteins of the endoplasmic 
reticulum (ER) resulted in a deeper understanding of how TPR-containing proteins 
contribute to protein homeostasis. The ER is a highly dynamic, multi-functional organelle 
responsible for several essential cellular processes. One third of the mammalian proteome 
is targeted to the ER for specialized folding and the ER possesses numerous factors that 
aid in this process, including TPR-containing proteins involved in protein translocation, 
co-chaperone function and protein modification. Approximately 40% of cellular TPR-
containing proteins have been suggested to contribute to maintaining the human 
proteostasis network and the TPR-containing proteins identified and characterized in this 
study contribute to protein homeostasis within the ER (Brehme et al., 2014; Graham et 
al., 2019). 
4.1 TMTC3 is a novel O-mannosyltransferase 
TMTC3 was found to O-mannosylate E-cadherin and be a member of a novel 
class of putative O-mannosyltransferases that modify the cadherin superfamily of 
proteins (Figure 2.5) (Larsen et al., 2017a). Studies on yeast protein O-
mannosyltransferases (Pmt1-7) and previously characterized mammalian POMT1 and 2 
showed that they form distinct complexes amongst each other and this complex formation 
is required for full mannosyltransferase activity (Gentzsch et al., 1995; Girrbach et al., 
2000). While the nature of the TMTC1-4 complexes is not known, sucrose gradient and 
co-affinity purification data shows that they interact with one another or have shared 




molecular weight complexes and interact with SERCA2B (Li et al., 2018; Sunryd et al., 
2014). TMTC2 and TMTC4 were also shown to interact with calnexin (Sunryd and 
Johan, 2014). Additionally, shot-gun proteomic analysis showed that TMTC3 may 
interact with both TMTC1 and TMTC2 as four and three unique TMTC3 peptides were 
identified from the affinity purified TMTC1 and TMTC2 samples, respectively (Sunryd 
et al., 2014).  
Preliminary sucrose gradient data overexpressing C-terminally S-tagged TMTC3 
and TMTC4 cDNA in HEK293T cells show that they may reside in higher molecular 
weight complexes (Figure 4.1A). TMTC3, while very faint, appears to be in a complex of 
approximately four times its size and TMTC4 appears to be in a complex of double its 
size indicating that they could exist in hetero- or homo-oligomers to form active O-
mannosyltransferases. Thus far, analysis has used overexpression systems to study these 
proteins, therefore, further studies are required to better understand how the endogenous 
TMTC family members interact with one another and what cellular role each plays. To 
circumvent the short-comings of overexpression, we could generate antibodies against 
the endogenous proteins or use the CRISPR system to endogenously tag TMTC1-4, 
individually (Lackner et al., 2015). This approach would better preserve the 
stoichiometry of the TMTC complexes allowing us to verify interactions with other 
proteins and potential sub-regional localization within the ER. It would also allow 
affinity purification of endogenous complexes for structural studies. 
Recently, affinity purification of FLAG-tagged Pmt1 revealed the first structure 
of an O-mannosyltransferase complex. The cryo-EM structure of the Saccharomyces 




helices and a luminal -trefoil fold that is the Mannosyltransferase, Inositol 1,4,5-
trisphosphate receptor and Ryanodine receptor (MIR) domain (Bai et al., 2019). The 
structure also reveals the substrate recognition model and catalytic site. TMTC3 and 
TMTC4 possess ten and twelve putative transmembrane segments, respectively (Figure 
2.1A). While we know that these proteins are integral membrane proteins and their C-
terminal TPR domains face the ER lumen, additional studies are necessary to fully 
understand their topology and how they might coordinate O-mannosyltransferase activity 
and substrate binding (Graham et. al submitted 2019). The Pmt1-Pmt2 complex showed 
that the two proteins interact via cytoplasmic loops and the transmembrane segments 
form a sizeable rhombic cavity that is proposed to allow the membrane-embedded donor 
substrate, Dol-P-Man, to diffuse into the catalytic site of the complex (Bai et al., 2019). It 
is possible that the TMTCs could form similar cavities, however structural studies are 
required to determine this and we have initiated studies with the researchers of the Pmt1-
2 cryo EM studies to solve the structure of TMTC3. 
In vitro [3H] mannose labelling studies in yeast indicated that a diacidic (Asp-Glu) 
motif located in an N-terminal luminal loop is the active site of the Pmt O-
mannosyltransferases (Lommel et al., 2011). Interestingly, all four TMTC proteins 
contain putative active residues located in an N-terminal loop. The recent structural study 
showed a small peptide substrate (PYTV) in complex with Pmt1-Pmt2 with the first 
residue in the diacidic motif (Asp77 in Pmt1 and Asp92 in Pmt2) ideally positioned to 
activate the hydroxyl of the acceptor threonine and the second residue (Glu78 in Pmt1 
and Glu93 in Pmt2) essential for forming a salt bridge with an invariant Lys in the first 




diacidic motifs within the first N-terminal loop, hydrophobic analysis combined with 
trypsin protection assays demonstrate that only TMTC3 and TMTC4 may have catalytic 
residues facing the ER lumen. Critical to understanding this structure function 
relationship is determining the orientation of each of the hydrophobic segments within 
these proteins. Structural analysis would be most informative, however cellular studies 
could be simultaneously performed as purifying multi-pass transmembrane proteins may 
be challenging. Using HEK293 TMTC1/2/3/4-/-, we can individually express the TMTCs, 
isolate ER-derived microsomes and perform [3H]-mannose labelling on previously 
described peptides to determine which TMTCs possess O-mannosylation activity 
(Lommel et al., 2011). We can then mutate residues within the TMTCs and perform the 
same assay to determine the putative catalytic sites. 
As mentioned previously, the TMTCs were found to O-mannosylate the cadherin 
family of proteins (Larsen et al., 2017a). It has recently been shown that the 
transmembrane region of protein O-mannosyltransferases coordinates the transfer of the 
Dol-P-Man to the donor substrate, however we do not know how the substrates are 
recruited to the active site. Based on studies on the MIR domain-containing protein, 
Stromal-derived factor 2 (SDF2), it has been suggested that the MIR domains present 
within the Pmts/POMTs are responsible for binding substrate and/or chaperones 
(Fujimori et al., 2017). As TPRs are protein-protein interaction motifs, we hypothesize 
that the C-terminal TPR domains of the TMTCs could interact with the repeat 
extracellular cadherin (EC) domains on cadherins to recruit them to the active site for O-
mannosylation (Figure 4.2B). The ARM repeat domains of -catenin have been shown to 




cadherin family members (Huber and Weis, 2001). The TPR motifs of OGT contain 
conserved Asn like the ARM repeat domains of -catenin that are responsible for the 
interaction with E-cadherin (Jínek et al., 2004). Similarly, TMTC3 and TMTC4 have a 
number of conserved Asn at positions 6 and 9 of their respective TPR consensus 
sequences.  
First, we would determine if the two classes of proteins, TMTCs and cadherins, 
interact. Previously performed affinity purifications and subsequent proteomic analysis of 
the TMTC proteins did not reveal interactions with cadherins, however, TPR-containing 
proteins often display transient interactions as scaffold proteins. In order to circumvent 
this issue, we can use TurboID in living cells to efficiently label interacting partners of 
the TMTCs by proximity (Branon et al., 2018). This system targets the protein of choice 
tagged with a biotin ligase to intracellular organelles using signal sequences to label 
endogenous proteins that come within a few nanometers of the bait protein. We can 
design both full-length and TPR domain rich constructs for the each of the TMTCs to 
identify interactors. If the TMTCs interact with cadherins, we can mutate the conserved 
Asn and perform the same assay to determine whether these residues are responsible for 
recruitment of substrate. Alternatively, we could endogenously CRISPR tag the TMTC 
proteins and perform biochemical analysis with intact complexes (Lackner et al., 2015). 
Glycosylation plays crucial roles in numerous cellular processes including cell-
cell recognition, signal transduction and ER protein quality control (ERQC) (D’Alessio et 
al., 2010; Haines and Irvine, 2003; Hart et al., 2007; Helenius and Aebi, 2004; Janik et 
al., 2010; Rambaruth and Dwek, 2011). Knockdown of the TMTCs results in a 




2017a). Cadherins are transmembrane proteins that mediate cell-cell adhesion, regulating 
cell contact formation and stability (Maître and Heisenberg, 2013). We found that O-
mannosylation of E-cadherin was primarily performed by TMTC3 and it affects cellular 
adherence through E-cadherin. Additionally, TMTC3 was the only TMTC that does not 
interact with SERCA2B, therefore, the TMTCs may play different cellular roles. In yeast, 
the different Pmt complexes exhibit specificity toward their protein substrates (Gentzsch 
and Tanner, 1997; Proszynski et al., 2004; Sanders et al., 1999). It is possible that the 
TMTC proteins O-mannosylate different classes of substrates and their subsequent O-
mannosylation affects the substrates differently. Recently, O-mannosylation has been 
implicated in ERQC by tagging slow folding substrates for proteasomal degradation (Xu 
et al., 2013). TMTC3 may affect the cell adhesion function of cadherins, while the other 
TMTCs may monitor folding of the cadherins and target them for degradation.  
To this end, we have acquired slow and fast folding GFP constructs that localize 
to the ER. Slow ER-GFP is demonstrated to be O-mannosylated and subsequently 
degraded in contrast to fast folding ER-GFP (Xu et al., 2013). Using HEK293 
TMTC1/2/3/4-/- cells, we can express these constructs in the presence of individual 
TMTCs and monitor both modification of the “slow” unfolded ER-GFP and its rate of 
degradation. Additionally, we can assess O-mannosylation of classic ERAD substrates as 
they accumulate in the ER with proteasomal inhibition in the presence of TMTCs. If O-
mannosylation by the TMTCs does not act to target proteins for degradation, it may be 
that they modify different substrates or different parts of the substrates affecting stability, 
localization or function of various secretory and membrane proteins (Lommel and Strahl, 




Since TMTC1, TMTC2 and TMTC4 have been found to interact with SERCA2B 
and regulate calcium dynamics, it is possible that they affect cadherin function through 
SERCA2B (Suisse and Treisman, 2019). Cellular calcium plays three major roles in 
cadherin mediated adherence. Calcium helps to rigidify the individual extracellular 
cadherin (EC) domains, define the structure of the dimer interface surfaces and opening 
of the A strand for strand swapping (Brasch et al., 2012). TMTC1-4 were found to be 
involved in the O-mannosylation of a number of ER resident proteins, including ERp57 
(Larsen et al., 2017a). It is possible that TMTC1, 2 and 4 affect calcium dynamics of 
SERCA2B by O-mannosylating ERp57 (Li and Camacho, 2004). To this end, we could 
assess calcium dynamics in HEK293 TMTC1/2/3/4-/- cells and compare it to WT 
HEK293 cells as well as samples that expressed the TMTCs individually (Sunryd et al., 
2014).  
Protein O-mannosylation is an essential protein modification in fungi and animals 
(Beltrán-Valero de Bernabé et al., 2002; Gentzsch and Tanner, 1996; Immervoll et al., 
1995; Mouyna et al., 2010; Willer et al., 2004, 2005). Defects in glycosylation have been 
found to be associated with human diseases. Mutations in TMTC3 have been shown to 
result in mild forms of Cobblestone Lissenceaphaly and Periventricular Nodular 
Heterotopia (PVNH) (Farhan et al., 2017; Jerber et al., 2016). Of the mutations we 
characterized, we find that three of the eight exhibit reduced stability in cells. While all 
are ER localized, it would be of interest to determine the mechanism of disease for the 
remaining five mutations. Biochemical analysis studies will include topology assessment, 
interacting partner analysis and in cell activity, and the ability to O-mannosylate E-




E-cadherin, however, further structural and biochemical analysis is necessary to 
understand its activity and disease phenotypes.  
4.2 TTC17 is a novel ER adaptor involved in ER stress 
TTC17 was identified as a novel TPR-containing protein resident to the ER. 
TTC17 transcripts were up-regulated significantly by a number of ER stress inducing 
reagents including N-glycan synthesis inhibition (tunicamycin), calcium depletion 
(thapsigargin), redox stress (dithiotreitol, DTT), inhibition of anterograde protein 
trafficking (brefeldin A) or proteasomal inhibition (MG132). Several essential ER 
chaperones are transcriptionally up-regulated by the UPR (Shinjo et al., 2013). ER stress 
activates stress sensors ATF6, IRE1 and PERK, representing the three branches of the 
UPR (Walter and Ron, 2011). Activation of each sensor produces a transcription factor 
that activates genes to increase folding capacity, ATF6, XBP1 and ATF4 respectively. 
These transcriptions factors, predominantly XBP-1, recognizes a sequence in the stress 
response genes defined as the ER stress response element (ERSE) (Roy and Lee, 1999). 
Preliminary analysis of the upstream region for the TTC17 transcript by promoter binding 
algorithms shows that it does not possess an ERSE.   
Interestingly, studies in yeast found that UPR-deficient cells are intolerant of ER 
stress and the heat shock response (HSR) can rescue ER stress in vivo (Liu and Chang, 
2008). ER heat shock protein (hsp) family members, BiP/GRP78 and GRP94, are not 
known to possess heat shock elements (HSE) in their promoters, however the yeast 
homolog of BiP (Kar2) was among the HSR target genes in the secretory pathway in 
UPR-deficient cells. Forty seven of 165 HSR target genes have functions in the secretory 




similar conditions in mammalian cells. TTC17 was found to be elevated in a mutant cell 
line that undergoes adaptive ER stress and is further increased upon raising the growth 
temperature (Pearse et al., 2008). This suggests that in mammalian systems, TTC17 
expression could be activated to alleviate increased ER stress.  
Initially, it would be of interest to characterize classic chaperones of the ER in the 
mutant cell line, MI8-5, both transcriptionally and translationally. In order to determine 
whether TTC17 directly regulates ER chaperones under stress conditions, we can delete 
TTC17 and monitor changes in expression of these chaperones. If there is no change in 
expression, global RNA and proteome profiling would be particularly useful to determine 
why TTC17 is up-regulated in the mutant cells, particularly at elevated growth 
temperature, as compared to wild type (WT).  
The overexpression system used to previously identify putative interacting 
partners of TTC17 could have resulted in false positives. Genetically manipulating both 
WT CHO and MI8-5 cells to both endogenously tag TTC17, as well as deleting it would 
be particularly beneficial to understand its function. First, we can repeat affinity 
purification and subsequent proteomic analysis on endogenously tagged TTC17 to 
maintain native complexes. Alternatively, we could express TTC17 full-length and 
truncated constructs in a TTC17 knockout cell line to identify natural binding partners 
and isolate interactors of the TPR clusters alone. Given that interactions with TPR 
domains are often transient, we can design a TurboID plasmid to target TTC17, full-
length and individual TPR clusters, to the ER and efficiently label interacting partners by 
proximity labelling (Branon et al., 2018). TTC17 resembles a TPR-containing protein 




most N-terminal TPR motif is directly followed by a coiled-coil domain, another protein-
protein interaction motif (Truebestein and Leonard, 2016).  
Interestingly, TTC13 came down in an affinity purified complex with TTC17. 
TTC13 was identified by bioinformatic analysis as another TPR-containing protein that is 
predicted to possess an ER targeting signal sequence (Appendix A1A) (Hessa et al., 
2007; Letunic and Bork, 2018; Nielsen, 2017). TTC13 has one predicted N-linked 
glycosylation site that does not appear to be recognized by endoglycosidases PNGaseF or 
EndoH (Appendix A1B) (Gupta, 2002). To this end, we genetically engineered two 
additional N-linked glycosylation sites at the N-terminus of TTC13 and observed a gel 
shift upon both PNGaseF and EndoH treatment indicating that TTC13 was targeted to the 
ER and has high mannose glycans similar to those of ER resident proteins (Appendix 
A1B). Immunofluorescence confocal microscopy of C-terminally tagged TTC13 shows 
that it co-localizes with ER marker, KDEL, and not the Golgi marker, GM130 (Appendix 
A1C). This confirms that TTC13 is an ER resident protein. Affinity purification of C-
terminally tagged TTC13 did not interact with TTC17 suggesting that the interaction 
isolated in the TTC17 affinity purification may involve the C-terminus of TTC13 
(Appendix A4). Analysis of TTC13 transcript regulation under ER stress conditions 
shows that it is not significantly up-regulated by stress however, it shares several putative 
interacting partners with TTC17 (Appendix A2 and A4).  
To examine the exact nature of the interaction between TTC13 and TTC17, the 
proximity labeling (TurboID) system could also be applied to TTC13. Alternatively, we 
can endogenously tag TTC13 using genetic manipulation, affinity purify it from cells, 




from cell lysates. Given that TTC17 is also heavily glycosylated, it would be more 
accurate to purify both TTC13 and TTC17 from mammalian cells using endogenous 
tagging and perform structural analysis. This can also be applied to each of the isolated 
TPR clusters within these proteins to identify their specific ligands.  
 Preliminary phenotypic analysis has been performed in cells and in animals to 
better understand both TTC13 and TTC17 function. To this end, eight shRNA constructs 
were designed for each TTC13 and TTC17, transfected into cells, and the cells were 
subsequently monitored for survival and morphological defects. No survival or 
morphology differences were observed. Analysis of TTC13 and TTC17 protein sequence 
conservation among commonly studied species, like TMTC analysis, revealed strong 
similarity to the TTC paralogues in Xenopus laevis. Morpholino sequences (Genetools 
LLC) were designed to match the ATG region of Xenopus laevis Ttc13 and Ttc17 to 
block protein translation of both allo allele (L and S). Individual morpholinos were 
microinjected into embryos at the 1-cell stage to ensure that every cell contained 
morpholino upon subsequent divisions. The injected embryos were allowed to develop as 
normal and a number of parameters were measured; including gastrulation, development, 
swimming phenotypes and survival. No significant differences were observed between 
morpholino injected embryos and non-injected controls suggesting that TTC13 and 
TTC17 do not play a major role in Xenopus development. However, it is possible that 
they play a functional role in stages beyond tadpole development or under certain 
environmental conditions. This study identified two novel ER TPR putative co-




cellular stress. Further biochemical and organismal studies are necessary to understand 
the role they play in maintaining cellular homeostasis and ER function. 
4.3 Summary 
 In this thesis, we have further characterized six novel ER proteins, with multiple 
TPR motif arrangements, that were identified from an in silico search for putative ER 
organization and functional adaptor proteins. Greater understanding of TPR-containing 
proteins has divided the six novel proteins into two distinct classes, proteins containing 
elongated clusters of TPR motifs (TMTCs) and co-chaperone-like proteins (TTCs) with 
three to four consecutive motifs. Previous studies implied that TMTC1 and TMTC2 are 
novel regulators of calcium homeostasis and TMTC4 was recently shown to also regulate 
cellular calcium. Current data, including this thesis, identifies TMTC1-4 as putative O-
mannosyltransferases of the cadherin family of proteins, proteins which greatly depend 
on calcium for function. It is possible that the TMTCs modify different substrates and 
therefore could regulate calcium homeostasis through modification of key calcium 
players, shedding light on a complicated and intricately regulated process. TTC17 
possesses two clusters of three and four TPRs, respectively, is regulated by ER stress and 
interacts with numerous chaperones indicating a co-chaperone-like role under stress 
conditions. Overall, a bioinformatic strategy was successful in identifying novel ER 
proteins with TPR motifs and biochemical characterization methods were successful in 
elucidating topology and putative function. While further analysis is required to 
understand their respective roles in maintaining ER homeostasis, this method can be 
applied to detect other common adaptor motifs such as the coiled-coil or ARM repeats in 





Figure 4.1. TMTC3 and TMTC4 reside in higher molecular weight complexes and may 
interact with substrate via conserved Asn. (A) HEK293T cells were transfected with S-
tagged TMTC3 or TMTC4 as indicated. Cells were lysed in MNT, and samples were 
layered on top of a continuous 10-40 % sucrose gradient in MNT buffer prior to 
ultracentrifugation. Fractions were collected from the top of the gradient, and proteins 
were precipitated with trichloroacetic acid. Immunoblotting was then performed with 
appropriate antisera as described above. Sizing of detected complexes was estimated by 
comparison to the following standards designated at the bottom of the immunblots; 
bovine serum albumin (4.6S, 66kDa); beta-amylase (8.9S, 200 kDa); and bovine 
thyroglobulin (19S, 669 kDa) (B) The ARM repeats of β-catenin interact with murine E-
cadherin at the residues indicated by dark grey circles on extracellular cadherin (EC) 




present on TMTC3 TPR motifs at positions 6 and 9 of the TPR consensus are indicated in 
the light grey circles. These conserved Asn are hypothesized to help recruit substrate for 
O-mannosylation, which takes place adjacent to the membrane at the putative active site 












Figure A1. TTC13 is an ER resident TPR-containing protein. (A) Our screen for novel 
secretory adapter proteins identified TTC13 as a putative TPR-containing protein that 
was potentially targeted to the ER by an N-terminal signal sequence (black square). The 
position of tetratricopeptide repeats (TPRs) (orange squares) is designated and predicted 
N-linked glycosylation sites are indicated by small, black, branched structures. Human 
TTC13 cDNA was C-terminally S-tagged (blue star) for biochemical studies. (B) 
HEK293T cells were transfected with S-tagged TTC13 WT or TTC13N96,117 and affinity 
purified from the cell lysate and media using S-protein agarose. Samples were then 
subjected to a glycosylation assay with either EndoH (lanes 2, 5, 8 and 11) or PNGaseF 
(lanes 3, 6, 9 and 12) digestion as indicated. Reducing sample buffer was added and the 
samples were analyzed by a 6% SDS-PAGE and immunoblotted for the S-tag epitope. 
(C) Cellular localization of TTC13 was investigated by confocal microscopy. HEK293A 
cells were transfected with human TTC13 cDNA. Fixed cells were stained with S-tag, 





Figure A2. Basal transcript abundance and fold induction of TTC13 by ER stress. (A) 
RNA from HEK293A cells, grown under normal conditions, was harvested. RNA was 
reverse transcribed to cDNA followed by qRT-PCR with appropriate primers. Basal 
mRNA abundance was assessed using β-actin as a reference. Error bars represent 
standard deviation from at least three independent experiments. (B) HEK293A cells were 
treated with regular growth media or with 2 mM DTT for 2 hr, 1 μg/mL tunicamycin, 3 
μM thapsigargin, 2.5 μg/mL brefeldin A or 2.5 μM MG132 for 24 hr prior to RNA 
purification. RNA was reverse transcribed to cDNA followed by qRT-PCR with 
appropriate primers, and changes in gene expression were calculated using β-actin as a 







Figure A3. TTC13 is a soluble protein that resides within the ER lumen. (A) Our screen 
for novel secretory adapter proteins identified TTC13 as a putative TPR-containing 




square). TTC13 contains 6 consecutive Cys (yellow ovals) within its signal sequence. 
TTC13 is one of eight non-redundant proteins with this feature. (B) TTC13 putatively 
contains a hydrophobic domain (blue) that resides at the end of the predicted signal 
sequence. Analysis of the N-terminal TTC13 protein sequence among mammalian 
species revealed similar features. (C) HEK293T cells, transfected with TTC13 and 
EDEM1 S-tag, respectively, were homogenized and fractionated prior to alkaline 
extraction. The fractions collected were whole cell lysate (WCL), nucleus (N), cytosol 
(C), total membrane (TM), as well as supernatant (S) and pellet (P) fractions upon 
alkaline extraction of the TM. The WCL, C, and S fractions were then precipitated with 
trichloroacetic acid, and all samples were resuspended in sample buffer prior to the 
proteins being detected by immunoblotting with antisera directed against S-tag, calnexin 






Figure A4. ER localized S-tagged TTC13 interacts with a number of chaperones. A 
shotgun liquid chromatography-mass spectrometry/mass spectrometry (LC-MS/MS) 
approach was used to identify potential binding partners of TTC17. HEK293T cells were 
transfected with TTC17-Stag plasmid followed by isotonic fractionation and 
ultracentrifugation to purify microsomes. The microsomes were resuspended in a buffer 
with detergent, and the tagged protein was affinity purified with S-protein agarose beads. 
The affinity purified complex was run on a short SDS-PAGE prior to in-gel trypsin 
digestion and silver staining. The peptides generated by trypsinization were loaded onto a 
LC-MS/MS instrument followed by peptide identification. Proteins were scored based on 
the number of unique peptides that were identified. The unique number of peptides was 
determined by averaging three independent experiments and then subsequently compared 
Common Name Mock  Unique Peptides Corrected
PDI 0 14 14
BiP 24 36 12
p180 4 14.5 11
Ribophorin I 0 10 10
GRP94 11 21 10
Heterogeneous nuclear ribonucleoprotein Q 0 9 9
OST48 0 9 9
Cold shock domain containing E1 2 11 9
Acetyl-CoA acyltransferase, mitochondrial 7 14 7
Peroxiredoxin-4 0 7 7
G protein-binding protein CRFG variant 0 7 7
Drebrin-like protein 0 7 7
highly similar to Homo sapiens zinc finger 
CCCH-type
0 7 7
Importin-5 7 14 7
ERp57 8 15 7
SERCA2B 10 16 6
⍺Glucosidase II 0 6 6
Synaptotagmin binding 0 6 6
highly similar to Dynamin-1-like protein 0 5 5
Ribophorin II 0 5 5
TCP-1-⍺ 14 19 5
Calreticulin 0 5 5
Sec61⍺ 1 6 5
weakly similar to ATP-dependent RNA 
helicase A
0 5 5
GCP60 0 5 5
ERp72 1 6 5
Serine/arginine-rich protein-specific kinase 1 0 4 4




to mock. The corrected column represents the difference and is displayed in ascending 
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